Open Collections

UBC Theses and Dissertations

UBC Theses Logo

UBC Theses and Dissertations

Chronic periodontitis is associated with platelet factor 4 (PF4) secretion. Brousseau-Nault, Mathieu 2016

Your browser doesn't seem to have a PDF viewer, please download the PDF to view this item.

Item Metadata

Download

Media
24-ubc_2016_november_brousseaunault_mathieu.pdf [ 18.53MB ]
Metadata
JSON: 24-1.0313403.json
JSON-LD: 24-1.0313403-ld.json
RDF/XML (Pretty): 24-1.0313403-rdf.xml
RDF/JSON: 24-1.0313403-rdf.json
Turtle: 24-1.0313403-turtle.txt
N-Triples: 24-1.0313403-rdf-ntriples.txt
Original Record: 24-1.0313403-source.json
Full Text
24-1.0313403-fulltext.txt
Citation
24-1.0313403.ris

Full Text

Chronic periodontitis is associated with platelet factor 4 (PF4) secretion  by  Mathieu Brousseau-Nault D.M.D., Université de Montréal, 2010   A THESIS SUBMITTED IN PARTIAL FULFILLMENT OF THE REQUIREMENTS FOR THE DEGREE OF   MASTER OF SCIENCE in THE FACULTY OF GRADUATE AND POSTDOCTORAL STUDIES (Craniofacial Science)   THE UNIVERSITY OF BRITISH COLUMBIA (Vancouver) August 2016 © Mathieu Brousseau Nault, 2016     ii Abstract   Aim: Platelets contribute to chronic inflammation but their role in periodontitis is not well understood. The aim of this study was to compare platelet recruitment and activation in healthy and inflamed periodontium.  Material and Methods: Gingival crevicular fluid (GCF) samples were obtained from sites of healthy periodontium, gingivitis and periodontitis. Platelets were quantified in the GCF by staining and microscopy. GCF concentrations of platelet factor 4 (PF4) [PF4]GCF and glycoprotein IIbIIIa ([GPIIbIIIa]GCF) were determined by ELISA. Blood samples were obtained from the 3 patient groups. Platelets were isolated from the whole blood and stimulated with lipopolysaccharides (LPS) from P. gingivalis to evaluate and compare the LPS-induced PF4 release.  Results: Compared to controls, platelet recruitment was increased at gingivitis and periodontitis sites, based on platelet counts and ([GPIIbIIIa]GCF). [PF4]GCF was elevated in periodontal pockets but not at gingivitis or healthy sites. Circulating plasma levels of PF4 were higher in patients with generalized severe periodontitis (SP), compared to patients with gingivitis or healthy periodontium. Platelets isolated from SP patients contained and released more PF4 in response to P. gingivalis LPS than platelets from gingivitis or periodontally healthy patients.  Conclusions: Periodontitis is associated with increased platelet activation and PF4 release, both locally and systemically.         iii Preface   This dissertation is an original intellectual product of the author, Mathieu Brousseau-Nault. All research involving human subjects was approved by the Clinical Research Ethics Board (CREB) at the University of British Columbia (“Platelet function in human periodontal disease”, certificate number H14-00100; and “Cytokines in human gingival crevicular fluid”, certificate number H14-00102). Mathieu Brousseau-Nault and Hugh Kim collected the gingival crevicular fluid (GCF) samples. Mathieu Brousseau-Nault collected all blood samples. Mathieu Brousseau-Nault performed all of the laboratory analysis with the exception of confocal microscopy, which was performed by Hugh Kim.                             iv Table of contents  Abstract…………………………………………………………………………………………... ii Preface…………………………………………………………………………………………... iii Table of contents……………………………………………………………………………….... iv List of tables………………………………………………………………………………........... vi List of figures…………………………………………………………………………................ vii List of abbreviations…………………………………………………………………................. viii Acknowledgements………………………………………………………………….................... ix Dedication………………………………………………………………….................................. x   Chapter One: Literature review……………….…………………………….…...…..……….. 1  Periodontitis: clinical and histological features………………………………………………….. 2 Definition, prevalence and significance………………………………………………………….. 2 Anatomy of the healthy periodontium………………………………………………………….... 2 Clinical and histological features of the diseased periodontium………………………………… 4 Gingivitis: clinical features………………………………………………………………………. 4 Gingivitis: histological features of the initial lesion……………………………………………… 5 Gingivitis: histological features of the early lesion………………………………………………. 5 Gingivitis: histological features of the established lesion………………………………………... 6 Periodontitis: the advanced lesion………………………………………………………………... 6 Clinical progression of periodontal disease………………………………………………………. 8  Pathogenesis of periodontal diseases…………………………………………………………….. 9 Overview: bacterial plaque and host-mediated tissue destruction……………………………….. 9 Pro-inflammatory cytokine signaling in the periodontium……………………………………… 10  Platelets as inflammatory cells………………………………………..………………………… 13 Platelet structure, activation and secretion……………………………………………..….......... 13 Platelets in chronic inflammatory diseases……………………………………………..…......... 14  Platelets in periodontal disease: indirect evidence……………………………………………… 15 Platelet factor 4 (PF4)…………………………………………………………………………… 15 Evaluating a direct role for platelets in periodontal disease..…………………………………… 16  Gingival crevicular fluid (GCF)………………………………………………………………… 18 GCF collection methods………………………………………………………………………… 20 Intracrevicular washing…………………………………………………………………………. 20 Absorbent paper filter strips……………………………………………………………………. 21 Capillary tubing or micropipettes………………………………………………………………. 22 Caveats of GCF sample collection……………………………………………………………… 23 Laboratory methods for GCF analysis………………………………………………………….. 24  Statement of the problem, aim and hypothesis…………………………………………………. 25    v Chapter Two: Chronic periodontitis is associated with platelet factor 4 (PF4) secretion… 26  Materials and methods…………..…………..…………..…………..…………..………………. 27 Recruitment of human subjects for the collection of gingival crevicular fluid (GCF)……......... 27  Clinical parameters for collection of GCF……………………………………………………… 27 Collection of GCF…………………………………………………………………………......... 28   GCF analysis…………………………………………………………………………................. 29 Recruitment of human blood donors and clinical parameters for blood collection…………….. 29 Human platelet preparation…………..…………..…………..…………..…………..…………. 30 Measurement of LPS-induced release of PF4…………..…………..…………..………………. 30 Statistical analysis…………..…………..…………..…………..…………..…………..………. 30  Results…………..…………..…………..…………..…………..…………..…………..………. 31  Discussion…………..…………..…………..…………..…………..…………..…………..…… 41 Platelets are recruited to sites of gingival inflammation…………..…………..…………..……. 41 PF4 is preferentially secreted during periodontitis…………..…………..…………..………….. 42 Periodontitis is correlated with systemic levels of circulating PF4…………..…………..……... 43  Chapter Three: Conclusions and future directions…………..…………..…………..……… 46  Bibliography…………..…………..…………..…………..…………..…………..…………….. 49                          vi List of tables   Table 1: Major histological and clinical features of gingivitis and periodontitis………………... 8  Table 2: List of platelet-derived cytokines………………………………………………………17  Table 3: Comparison of three methods for gingival crevicular fluid (GCF) collection………... 20  Table 4: Periodontal characteristics of blood donors…………………………………………... 34                                        vii List of figures   Figure 1: Structure of the periodontium…………………………………………………………. 3  Figure 2: Healthy gingival tissues……………………………………………………………….. 3   Figure 3: Illustration of periodontal probing…………………………………………………….. 4  Figure 4: Clinical characteristics of gingivitis…………………………………………………... 4  Figure 5: Clinical and histological features of periodontal health and disease………………….. 7  Figure 6: Relationship between dental plaque, host response and tissue degradation…………. 10  Figure 7: Pro-inflammatory cytokine signaling………………………………………………...  11  Figure 8: Cytokine signaling in the “established” lesion……………………………………….  12  Figure 9: Structure of resting and activated platelets…………………………………………..  14  Figure 10: Gingival crevicular fluid (GCF)……………………………………………………. 19   Figure 11: GCF collection by micropipette…………………………………………………….  22  Figure 12: Sources of GCF contamination…………………………………………………….. 23  Figure 13: Algorithm for GCF sample collection and classification…………………………... 35  Figure 14: Platelets are recruited to sites of periodontal inflammation………………………...  36  Figure 15: GCF concentrations of platelet factor 4 (PF4) are elevated in periodontal pockets... 37  Figure 16: Circulating PF4 and platelet loading of PF4 is elevated in patients                     with generalized severe chronic periodontitis…………………………….………... 38  Figure 17: LPS-induced PF4 release is amplified from platelets isolated                     from patients with generalized severe chronic periodontitis……....……………….. 39  Figure 18: Proposed model of platelet recruitment and PF4 release in the periodontium……... 40        viii List of abbreviations   ANOVA One-way analysis of variance APC  Antigen-presenting cells BOP  Bleeding on probing  CCL  Chemokine C-C motif ligand  CXCL  Chemokine C-X-C motif ligand DGJ  Dento-gingival junction ELAM-1 Endothelial cell leukocyte adhesion molecule-1 ELISA  Enzyme-linked immunosorbant assay FITC  Fluorescin isothiocyanate FMLP  N-formyl-methionyl-leucyl-phenylalanine GCF  Gingival crevicular fluid GPIIbIIIa Glycoprotein IIbIIIa  HMGB High mobility group box ICAM-1 Intercellular adhesion molecule-1 Ig  Immunoglobulin IGF  Insulin-like growth factor IL  Interleukin JE  Junctional epithelium LPS  Lipopolysaccharide MGI  Modified Gingival Index MMP  Matrix metalloproteinase OCS  Open canalicular system PAF  Platelet activation factor PBS  Phosphate buffered saline PD  Probing depth PDL  Periodontal ligament PDGF  Platelet-derived growth factor PI  Plaque index PF4  Platelet factor 4 PMN  Polymorphonuclear neutrophils RANTES Regulated on Activation, Normal T Cell Expressed and Secreted ROS  Reactive oxygen species SD  Standard deviation SEM  Standard error of the mean TGF-β  Transforming growth factor beta TLR  Toll-like receptor TNF-α  Tumor necrosis factor-alpha Tregs  Regulatory T-cells      ix Acknowledgements   I would first like to thank my supervisor, Hugh Kim, who has inspired me to continue my work in this field. Your guidance was much appreciated.  I would also like to thank the other members of my research committee, Jayachandran N. Kizhakkedathu and Donald Brunette for their guidance, commitment and for broadening my vision of science.  I would also thank Graham Lee and Babak Chehroudi for their assistance with subject recruitment, as well as Christopher Overall, Georgina Butler, Brana Culibrk and Iren Constantinescu for technical assistance as well as Edward Conway for helpful suggestions.  To my parents Gilles and Michèle, my godmother Nathalie and godfather Marc, for their unconditional love and support throughout all my studies and my career. You have inspired me to become a better person. Merci.                    x Dedication   To my sisters Camylle and Alice:  Throughout my life, I have always strove to fulfill my potential in order to become the best person I could be. With this decision, however, came the painful sacrifice of spending less time with you. May my accomplishment be a source of motivation for you, and I hope you can appreciate that each of you can realize whatever dream you cherish, as long as you are ready to put forth the necessary hard work and discipline.  1          Chapter One: Literature review    2 Periodontitis: clinical and histological features  Definition, prevalence and significance Periodontitis, commonly referred to as “gum disease”, is a chronic oral infection that is characterized by the degradation of the tooth-supporting tissues, collectively termed the periodontium (Fig. 1). Based on data from the large-scale National Health and Nutrition Examination Survey, periodontitis affects up to half of the adult population of the United States (Eke et al., 2015). Left untreated, the continued destruction of tooth-supporting structures eventually leads to significant morbidity and tooth loss. In addition, considerable evidence indicates that periodontitis confers an increased susceptibility to serious systemic diseases such as diabetes (Taylor et al., 2013) and atherosclerosis (Lockhart et al., 2012; Bartova et al., 2014a) Consequently, there is considerable impetus to improve upon existing diagnostic strategies, risk assessments and therapeutics for this highly prevalent disease.  Anatomy of the healthy periodontium Teeth are supported by bone, a periodontal ligament and soft gingival tissues (gingiva); these tissues are collectively referred to as the periodontium (Fig. 1). The aspect of the gingiva facing the oral cavity is the oral epithelium. The cells of the oral epithelium project downwards into the underlying connective tissue; these projections are called rete pegs. The gingiva attaches to the tooth at the dento-gingival junction; this is a critical interface whose integrity is essential for periodontal health. The gingival sulcus is the crevice between the gingiva and the tooth surface. This space is lined with sulcular epithelium and contains a fluid called gingival crevicular fluid (GCF). The adhesion between gingiva and teeth is mediated by a junctional epithelium (Nanci  3 and Bosshardt, 2006). The gingival connective tissue is subjacent to the junctional epithelium and is firmly attached to the root surface by collagen fibers known as Sharpey’s fibers. The fibroblast is the predominant cell in the gingival connective tissue; mast cells, macrophages and other inflammatory cells are also present (Lindhe et al., 2008; Golijanin et al., 2015).  Figure 1. Schematic diagram depicting the structure of the periodontium. Left panel: Cross-section of a tooth illustrates the bone (B), the gingiva (G) and the periodontal ligament (PDL). The dento-gingival junction is circled in green. Right panel: Detailed schematic of the dento-gingival junction (DGJ, green circle). The crevice between the tooth and the gingiva is the sulcus; the base of the sulcus is termed the junctional epithelium (JE) that mediates gingival adhesion to the tooth.    Clinically healthy gingival tissues have a firm consistency, are coral pink in color and exhibit knife-edge margins (Fig. 2). In addition, periodontal health is quantified by measurements of sulcus depth, or probing depth (Fig. 3). Sulcus (probing) depths of 1-3 mm are consistent with periodontal health. Conversely, tissue degradation from periodontal disease results in pathologically deepened sulci that are termed periodontal pockets (Fig. 3).  Figure 2. Photograph depicting healthy gingival tissues. Clinically, healthy gingiva is characterized as coral pink, with a firm texture and knife-edge margins (arrows).  Knife edge margins Coral pink color G B PDL Sulcus JE DJG DGJ  4     1.3   1.3. Clinical and histological features of the diseased periodontium  In broad terms, most periodontal diseases are classified as either (1) gingivitis, that is confined to the soft gingival tissues; and (2) periodontitis, characterized by concomitant degradation of the periodontal ligament and alveolar bone (Armitage, 1999). Periodontal diseases are initiated by the accumulation of bacteria-laden dental plaque at the dento-gingival junction (Fig. 3).  Gingivitis: clinical features During gingivitis, the tissues exhibit the four (4) cardinal signs of inflammation, namely redness, bleeding, swelling and less commonly, pain (Page and Schroeder, 1976; Armitage, 2004b; Lindhe et al., 2008). A classical study of experimentally-induced gingivitis determined that clinically-observable gingivitis occurs in 10 to 21 days following abstention from oral hygiene measures (Loe et al., 1965).  Figure 4. Clinical photograph depicting gingivitis. Gingival inflammation is characterized by erythema (redness), edema and rolled gingival margins (arrows). Clinically detectable gingivitis corresponds with the “early” or “established” gingival lesions described by Page and Schroeder (1976). Inflamed  tissue Probe Bacterial plaque PERIODONTAL HEALTH PERIODONTAL DISEASE Figure 3. Schematic diagram illustrates periodontal probing as a quantifiable measure of periodontal health. Left: healthy gingival sulci are 1-3 mm deep. Right: in diseased periodontium, tissue destruction leads to pathologically deepened sulci, called periodontal pockets. Note the bacterial plaque at the dento-gingival junction. Probing depths are recorded at several points (sites) around each tooth. Rolled margins Erythema Edema  5 Gingivitis: histological features of the initial lesion Page and Schroeder published a classical paper detailing the histopathological features of gingivitis and periodontitis (Page and Schroeder, 1976). The authors divided the gingivitis lesions into 3 distinct phases, describing them as the “initial”, “early” and “established” lesions. The clinical and histological features of these lesions are illustrated in Figure 5 and summarized in Table 1. First, the initial lesion emerges within 2-4 days of exposure to the dental plaque (Page and Schroeder, 1976) and is a subacute form of gingivitis that is not clinically detectable. Histologically, the initial lesion is characterized by local vasodilation, an increase in vascular permeability, and the influx of polymorphonuclear cells (PMNs) into the junctional epithelium and gingival sulcus. Within the gingival connective tissues, the perivascular collagen is degraded, creating additional space for the influx of fluid and inflammatory cells (Page and Schroeder, 1976).   Gingivitis: histological features of the early lesion After 4-7 days of plaque accumulation, the initial lesion intensifies and becomes known as the early lesion (Page and Schroeder, 1976). Continued degradation of the gingival connective tissues results in a 60-70% loss of collagen, thus providing even more space for the inflammatory infiltrate (Page and Schroeder, 1976). In addition to PMNs, the cellular infiltrate of the early lesion contains macrophages and lymphocytes within the gingival connective tissue (Listgarten and Ellegaard, 1973; Payne et al., 1975; Seymour et al., 1983; Brecx et al., 1987). Histologically, there is marked proliferation of both basal cells of the junctional epithelium and the epithelial rete pegs (Schroeder, 1970; Schroeder and Munzel-Pedrazzoli, 1973). During the early lesion, the increased permeability and proliferation of the  6 vasculature result in clinically detectable gingival erythema and edema (Lindhe and Rylander, 1975).   Gingivitis: histological features of the established lesion The established lesion follows from the early lesion and occurs within 2-3 weeks of plaque accumulation (Page and Schroeder, 1976). In contrast to the early lesion, the established lesion is distinguished by the predominance of antibody-producing plasma cells within the connective tissues (Page and Schroeder, 1976). Accordingly, there are large amounts of immunoglobulin present in the connective tissues and in the junctional epithelium (Page and Schroeder, 1976). The lesion is still confined to the gingival connective tissue although there is continued tissue degradation (Page and Schroeder, 1976). There is also ongoing proliferation, apical migration, and lateral extension of the junctional epithelium as rete pegs that extend deeper into the connective tissue (Lindhe et al., 2008). Clinically, the established lesion can manifest as red or cyanotic gingiva with rolled margins. The interdental gingiva (between adjacent teeth) can become bulbous, flattened, blunted or cratered. The established lesion can remain stable and stay confined to the gingival connective tissues for an indefinite period of time; alternatively, the established lesion can convert to an advanced lesion characterized by destruction of the underlying periodontal ligament and alveolar bone (Page and Schroeder, 1976).   Periodontitis: the advanced lesion In contrast to the established gingivitis lesion that is limited to the gingival connective tissues, the advanced lesion involves degradation of the tooth-supporting alveolar bone and  7 periodontal ligament; the corresponding clinical condition is termed periodontitis. In addition to the alveolar bone loss that is discernable on dental radiographs, a critical feature of periodontitis is the downward migration of the junctional epithelium onto the root surface (Page and Schroeder, 1976; Armitage, 2004c), thus creating a periodontal pocket that is clinically measurable with a periodontal probe (Fig. 3). As is observed in the established lesion of gingivitis, plasma cells dominate the advanced lesion of periodontitis (Berglundh and Donati, 2005). Eventually, in the more advanced stages of the disease, teeth become  mobile due to erosion of bone support, potentially leading to tooth loss.                      Figure 5.  Diagram illustrating the correlation between the clinical presentation (A), the Page and Schroeder classification (B) and the histological features (C) of periodontal health, gingivitis and periodontitis. The early and established lesions described by Page and Schroeder (1976) correspond with clinically detectable gingivitis in the absence of bone loss; the advanced lesion corresponds to periodontitis featuring bone loss that is visible on a dental radiograph.    HEALTH INITIAL ! EARLY ! ESTABLISHED (Page and Schroeder) ADVANCED LESION (Page and Schroeder) BONE GINGIVITIS PERIODONTITIS A. B. C. PMN influx Inflammatory Infiltrate (PMNs, lymphocytes, plasma cells) Collagen degradation BONE LOSS  8 Table 1. Summary of the major histological and clinical features of the initial, early, established and advanced lesions described by Page and Schroeder (1976).   Gingivitis Initial lesion Gingivitis Early lesion Gingivitis Established lesion PERIODONTITIS Advanced lesion Time after plaque accumulation  2-4 days  4-7 days  14-21 days   Major cells PMNs Lymphocytes Plasma cells Plasma cells Major structural changes Vascular dilation  Perivascular collagen loss Increased collagen loss (70% loss)  Loss of coronal portion of JE Extravascular IgG present  JE converts to pocket epithelium Loss of connective tissue, PDL and alveolar bone  Irreversible clinical attachment loss Clinical findings Tissues appear clinically healthy Erythema  Bleeding on probing Marked edema  Can remain stable for months/years or convert to advance lesion Increased probing depth (pocket)  Bone loss observed on radiograph and clinically  Clinical progression of periodontal disease In susceptible hosts, the clinical and histological changes that occur in response to plaque accumulation occur at different rates in different individuals (Loe et al., 1986; Michalowicz, 1994; Kornman et al., 1997). A classical study on the natural history of untreated periodontal disease in humans (Loe et al., 1986) found that 11% of the patient cohort exhibited stable gingivitis lesions that did not progress to periodontitis. Among those who did develop periodontitis, there was considerable variability in the rate of disease progression, with 81% of the patients exhibiting “moderate” progression and 8% of patients exhibiting “rapid” disease progression. This wide variation in the incidence of disease onset (and speed of disease progression) is likely attributable to individual differences in the molecular-level host response to bacterial pathogens (Bartold and Van Dyke, 2013; Silva et al., 2015). However, the precise  9 signaling mechanisms in the periodontium that regulate the onset and speed of disease progression remain incompletely understood.   Pathogenesis of periodontal diseases  Overview: bacterial plaque and host-mediated tissue destruction The primary etiology of periodontal disease is the colonization of the dento-gingival junction by gram-negative, anaerobic pathogens present in dental plaque (Loe et al., 1965; Hasan and Palmer, 2014). More than 15 microorganisms have been identified as putative etiologic agents for periodontal disease (1996; Perez-Chaparro et al., 2014). A “red complex” of pathogens has been identified, whose presence in the periodontium is closely correlated with periodontal disease severity (Socransky et al., 1998). The three pathogens in this notorious “red complex”, Porphyromonas gingivalis, Treponema denticola and Tannerella forsythia, exhibit virulence factors that exert noxious effects on the periodontium (Holt and Ebersole, 2005b). For instance, P. gingivalis secretes cysteine proteases known as gingipains that degrade connective tissues (Andrian et al., 2004; Carvalho-Filho et al., 2016). Notably, the bacterial cell walls of gram-negative pathogens contain lipopolysacharide (LPS), which activates the host inflammatory response and initiates periodontal tissue destruction by engaging toll-like receptors (TLRs) on the surface of immune cells in the periodontium, such as neutrophils, monocytes, macrophages and dendritic cells (Nair et al., 1983; Kayal, 2013; How et al., 2016). Activation of the host response immune signaling cascade ultimately accounts for the bulk of the tissue destruction observed in periodontitis (Figs. 6-8). For example, neutrophils (PMNs) remove bacteria by phagocytosis but also leach proteolytic enzymes that degrade the connective tissue. Moreover, the macrophages, lymphocytes and plasma cells that populate periodontal  10 lesions communicate through soluble, low molecular weight proteins known as cytokines (Graves, 2008; Deo and Bhongade, 2010). Cytokines serve to recruit additional inflammatory cells to the periodontium, and also signal the release of collagen-degrading enzymes such as matrix metalloproteinases (MMPs) by resident cells of the gingival connective tissues (Fig. 7). Therefore, while the immune response is essential for the host’s defense against bacterial infection, an overactive immune response and/or over-secretion of host-derived cytokines exacerbates periodontal tissue destruction.       Figure 6. Flow diagram illustrating the relationships between bacterial infection (blue type), the host response (red type), and clinically detectable periodontal disease. The host response encompasses the inflammatory cells recruited to the periodontium and the cytokines/enzymes secreted in response to the bacterial infection. Although bacteria can degrade tissue directly (e.g. gingipains from P. gingivalis), the bulk of the tissue destruction is secondary to the host immune response.   Pro-inflammatory cytokine signaling in the periodontium Initial lesion: Neutrophils (PMNs) are the dominant cell type of the initial lesion. At the outset of periodontal infection, the junctional epithelium (Fig. 1) secretes interleukin-8 (IL-8), a cytokine that recruits PMNs to the dento-gingival junction in a process known as chemotaxis (Tonetti et al., 1998). Bacteria also release N-formylmethionine-leucyl-phenylalanine (FMLP), a peptide that is chemotactic for PMNs (Scott and Krauss, 2012). In addition, the complement  Periodontal pathogen  Gingivitis   LPS Cytokines Enzymes Host response Dental plaque Tissue destruction and  clinical disease Bone loss Periodontitis Complement PMNs Macrophages Lymphocytes Plasma cells Platelets Direct tissue degradation by bacteria ???  11 MMP-1 (collagenase) release Tissue degradation IL-1 Macrophage Gingival fibroblast Bacteria LPS TLR IL-1R IL-1 receptor system consists of a group of nine (9) proteins whose sequential activation leads to lysis of bacterial cells; one of the complement proteins (C5) is chemotactic for neutrophils (Van Dyke et al., 1983; Hajishengallis, 2010). Once the PMNs are recruited to the site of infection, vascular adhesion molecules such as ELAM-1 facilitate the PMN’s exit from the circulation into the tissues (Moughal et al., 1992) through a process known as diapadesis.  While the bactericidal properties of PMNs are central to the innate immune response, prolonged PMN activity and degranulation results in the release of PMN-derived proteases that contribute to periodontal tissue destruction (Ohlsson et al., 1974; Scott and Krauss, 2012).          Early and established lesions: The early and established gingivitis lesions are populated by macrophages, lymphocytes and plasma cells. Like PMNs, the activities of macrophages and lymphocytes can propagate periodontal inflammation and tissue degradation. For example, macrophages destroy bacteria by phagocytosis but also secrete interleukin-1 (IL-1), a cytokine that signals the release of MMP-1, a collagen-degrading enzyme, from human gingival fibroblasts (Havemose-Poulsen and Holmstrup, 1997; Domeij et al., 2002) (Fig. 7). Macrophages also release tumor necrosis factor-alpha (TNF-α), a cytokine which promotes the formation of bone-resorbing osteoclasts (Ukai et al., 2008; Hienz et al., 2015).  Figure 7. An example of pro-inflammatory cytokine signaling in the periodontium. LPS from gram-negative pathogens activate toll-like receptors (TLRs) on macrophages triggering release of interleukin-1 (IL-1) stimulates the release of tissue-degrading collagenase from resident gingival fibroblasts.   12 Plasma cells pmn Antibody production Antigen presentation Secretion - IL-4 - IL-5 Bacteria Macrophage Th2 cell B cell Plasma cell Bacterial lysis Complement activation 1. 2. 3. 4. PMN chemotaxis The interplay between macrophages, lymphocytes and plasma cells in the “established” gingival lesion can be summarized as follows (Fig. 8). After ingesting pathogens, macrophages serve as antigen-presenting cells to helper T-lymphocytes (Sloan-Lancaster et al., 1993) that respond by secreting interleukin-4 (IL-4) and interleukin-5 (IL-5). These cytokines signal the differentiation of B-lymphocytes into antibody-producing plasma cells (Berglundh and Donati, 2005). Antibodies against periodontal pathogens activate the complement system thus facilitating bacterial destruction (Cekici et al., 2014), however, the chemotactic effects of complement serve to recruits additional PMNs whose continued degranulation contributes to tissue degradation.             Figure 8. Cytokine signaling in the established lesion. Diagram illustrates crosstalk between macrophages, T-lymphocytes and B-lymphocytes (plasma cells). Macrophages phagocytose bacterial pathogens (e.g. P. gingivalis) and function as antigen-presenting cells to Th2 helper lymphocytes, who in turn secrete IL-4 and IL-5, thus signaling the differentiation of B-cells into IgG-producing plasma cells. Antibodies produced (1) serve to activate complement (2) which facilitates bacterial lysis (3) but also promotes PMN chemotaxis (4) whose degranulation promotes further tissue destruction in the periodontium.    SUMMARY: Gram-negative periodontal infections trigger a local influx of immune cells (PMNs, macrophages, T-lymphocytes, B-lymphocytes), and activation of the complement cascade. These responses can be both protective and destructive for the periodontium. The functions of these immune cells in the periodontium are controlled by complex (and incompletely understood) cytokine signaling networks that determine an individual’s disease susceptibility and rate of disease progression.  13 Platelets as inflammatory cells The roles played by PMNs, macrophages and lymphocytes (and their cytokines) in orchestrating and propagating periodontal inflammation have been extensively reported in the scientific literature (Yucel-Lindberg and Bage, 2013; Hajishengallis, 2014; Hajishengallis et al., 2014; Hajishengallis and Sahingur, 2014; Silva et al., 2015). In contrast, much less is known about how platelets contribute to periodontal disease pathogenesis. Platelets are small anucleate blood cells approximately 1-3 µm in diameter, and are released into the bloodstream by megakaryocytes in the bone marrow. In their quiescent state, platelets circulate as small discs for 8-9 days prior to being cleared by the liver. Platelets are by far the most numerous cells in the bloodstream, circulating at concentrations of 150,000-450,000 cells per microliter of blood.  Platelet structure, activation and secretion Like other eukaryotic cells, platelets have a membrane-bound cytoplasm containing organelles including a Golgi apparatus and rough endoplasmic reticulum (Ts'ao, 1971; Lu et al., 2013). The plasma membrane contains multiple cell surface receptors (Fig. 9) that recognize extracellular signaling molecules, or ligands (Saboor et al., 2013). A unique feature of platelets is that they contain three types of secretory granules: the alpha-granules, the dense granules and the lysosomes (Gremmel et al., 2016). Upon activation by soluble agonists or vascular injury, resting platelets rapidly change shape, aggregate and secrete the contents of their granules (Fig. 9).  Notably, the plasma membrane is continuous with an extensive invaginated network of membranes, collectively known as the open canalicular system, which opens to the extracellular space, thus providing a conduit for the release of granular content (White and Krumwiede, 1987).   14 LPS Dense Alpha Lysosome TLR4 GPIIbIIIa PF4 PDGF Serotonin Histamine Acid  phosphatase Cytokine release Platelet activation OCS Granule fusion with plasma membrane Agonist-receptor binding Shape change          Figure 9. Schematic diagram of platelet activation. Left: resting platelets store biological mediators in 3 principal types of granules: α-granules, dense granules and lysosomes. The plasma membrane is contiguous with a complex of invaginated membranes known as the open canalicular system (OCS). Cell surface receptor TLR4 on platelets recognizes LPS from periodontal pathogens. Right: Upon binding of receptors (e.g. TLR4) with a soluble agonist (e.g. LPS), platelets become activated and change shape. Activation is accompanied by fusion of the granule membranes with the plasma membrane and OCS and extracellular relase of cytokines.  Platelets in chronic inflammatory diseases Platelets are best known for their functions in hemostasis and thrombosis. Platelet granules store and release over 30 different cytokines, many of which have documented roles in inflammation (Table 2). Accordingly, a growing body of evidence suggests that platelets are important contributors to chronic inflammation. For example, arthritic disease is milder in thrombocytopenic mice compared to controls (Semple et al., 1996). Humans affected by rheumatoid arthritis show elevated platelet activity in vitro (Mac Mullan et al., 2010) and also exhibit elevated plasma levels of soluble P-selectin (Sfikakis et al., 1999) and soluble CD40 ligand (Goules et al., 2006), two molecules released by activated platelets. Similarly, platelet activity is elevated in patients with inflammatory bowel disease (Danese et al., 2004; Yoshida  15 and Granger, 2009; Scaldaferri et al., 2011; Stadnicki, 2012). Collectively, these data support the association between platelet activation and chronic inflammation.  Platelets in periodontal disease: indirect evidence Recently published data point to a general association between platelet activity and periodontitis. In an experimental periodontitis study in rats, systemic administration of anti-platelet drugs attenuated the severity of experimentally-induced bone loss while reducing circulating levels of the pro-inflammatory mediators interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-α) (Coimbra et al., 2011). In a separate animal study, the same authors found that systemic administration of the antiplatelet drug clopidogrel reduced neutrophil infiltration at sites of experimental periodontitis (Coimbra et al., 2014), suggesting that platelets have a net pro-inflammatory function. In humans, platelet counts are reportedly higher in patients with chronic periodontitis versus controls (Al-Rasheed, 2012a). Moreover, platelets from periodontitis patients are more responsive to oral bacteria than platelets from control subjects (Nicu et al., 2009a). The same group studied plasma levels of platelet-derived molecules in periodontitis patients (Papapanagiotou et al., 2009). They reported that periodontitis was associated with increased plasma levels of soluble P-selectin. Taken together, these data are consistent with the notion that periodontal inflammation is directly correlated with systemic platelet activity.   Platelet factor 4 (PF4) The pro-inflammatory properties of platelets are perhaps most likely attributable to platelet factor 4 (PF4), an 8-kDa platelet-specific cytokine that is the major constituent stored and released from platelet alpha-granules. PF4 accounts for approximately 25% of the platelet’s protein  16 content (Zucker and Katz, 1991). Significant evidence points to PF4 as a pro-inflammatory cytokine. For example, PF4 stimulates neutrophil degranulation (Bebawy et al., 1986) and is also chemotactic for monocytes and promotes their differentiation into macrophages (Scheuerer et al., 2000). Moreover, PF4 appears to nullify the anti-inflammatory properties of regulatory T-lymphocytes (Tregs) (Liu et al., 2005). In addition, PF4 is implicated in the pathogenesis of several chronic inflammatory diseases, including atherosclerosis (Aidoudi and Bikfalvi, 2010b), suggesting that PF4 is the cytokine that drives the pro-inflammatory effects of platelets. However, the role of PF4 has not been specifically evaluated in the context of periodontal disease.  Evaluating a direct role of platelets in the periodontal disease Despite indirect evidence of the contribution of platelets to periodontal inflammation, there have been no direct studies of platelet recruitment, activation and secretion in the periodontium. Since platelets, like neutrophils, are chemotactically responsive to bacteria-derived FMLP (Czapiga et al., 2005), it is plausible that platelets are recruited to the inflamed periodontium. Conceivably, platelets recruited to the periodontium are readily activated by bacterial LPS since platelets express toll-like receptor 4 (TLR4), the receptor for bacterial LPS (Zhang et al., 2009a). These data support a biologically plausible mechanism by which platelets could contribute to  periodontal inflammation. A logical approach to evaluating platelet recruitment and activity in the periodontium would be to study platelet-specific markers in the gingival crevicular fluid (GCF), a secretion obtained from the microenvironment of the dento-gingival junction.       17  Table 2. Partial list of platelet-derived cytokines, their cellular location, known physiological effects and (possible) role in periodontal inflammation.  Location in platelet Cytokine General role Potential relevance to the periodontium References                Alpha Granule                   PF4 Activates monocytes Promotes inflammation (Engstad et al., 1995) RANTES Attracts and activates macrophages and lymphocytes Increase recruitment of inflammatory cells  (Gamonal et al., 2000b) IL-8  Chemoattractant cytokine for neutrophils Increases neutrophil influx (Bickel, 1993) PDGF  Improves soft tissue healing Promotes regeneration (Lynch et al., 1989) IGF  Reduces apoptosis in PDL fibroblasts Promotes regeneration (Han and Amar, 2003) TGF-β Promotes matrix formation Stimulates collagen synthesis (Sodek and Overall, 1992) Thymosin-B4 Promotes wound healing Diminishes inflammation (Sosne et al., 2010) Epithelial growth factor Promotes stimulation PGE2 Promotes bone resorption (Carpenter and Cohen, 1979; Chang et al., 1996) Hepatocyte growth factor Promotes epithelial invasion Contributes to periodontal disease progression (Gherardi and Stoker, 1991; Rudrakshi et al., 2011) CCL3 Stimulates osteoclast differentiation Promotes bone resorption (Watanabe et al., 2004) CXCL1 Chemotactic for neutrophils, supports PMNs adhesion to endothelial cells Promotes periodontal disease progression (Bender et al., 2008) CXCL5 Chemotactic for PMN Increase neutrophil influx (Leppilahti et al., 2014) Thrombocidins Antibacterial  peptides  Promotes pathogen destruction (Clemetson, 2011; Semple et al., 2011)  Dense Granule Serotonin Stop osteoblast proliferation Disrupts bone homeostasis (Carvalho et al., 2010)  Lysosome   Collagenase Collagen degradation  Destruction of connective tissue (Mancini et al., 1999) Elastase Involved in destruction of PDL Promotes progression of periodontitis (Ujiie et al., 2007)  18 Lysosome Cathepsin Proteolytic activities Promotes tissue destruction (Soell et al., 2002) Not known CCL7 Chemotactic to monocytes, activates T-lymphocytes, eosinophils and basophils Promotes inflammation (Ong et al., 2003; Wetzel et al., 2007) IL-1β Promotes bone resorption, stimulates secretion of PGE2 and MMP Promotes periodontal breakdown (Gamonal et al., 2000a) HMGB1 Activate monocytes, releases pro-inflammatory mediators Promotes periodontal tissue destruction (Luo et al., 2011) Plasma membrane PAF Promotes leukocytes degranulation Promotes inflammation and tissue destruction (Emingil et al., 2001a; Chen et al., 2010)  CD40 Upregulates inflammatory response in numerous cells Promotes inflammation (Noelle, 1996; Chaturvedi et al., 2015)  Gingival crevicular fluid (GCF)  Overview As noted earlier, the dento-gingival junction harbors a gingival crevicular fluid (GCF) that flows continuously through the sulcus (Fig. 10). The GCF is a transsudate originating from the blood vessels in the gingival connective tissues and contains soluble proteins secreted by local host inflammatory cells (Delima and Van Dyke, 2003). Leukocytes, predominantly neutrophils, are the most abundant inflammatory cells in the GCF (Egelberg, 1963; Attstrom, 1970; Skapski and Lehner, 1976; Wilton et al., 1976; Kowolik and Raeburn, 1980; Sandholm, 1984; Saito et al., 1987; Kennett et al., 1997). The GCF serves to dilute bacterial toxins (Goodson, 2003) and also contains antibacterial proteins such as complement proteins, immunoglobulins, lactoferrin and alpha-1 antitrypsin (Kido et al., 2012; Huynh et al., 2015). Moreover, the outward flow of GCF  19 !"#Blood vessels Fibroblast Macrophages Neutrophils GCF  Cytokines  helps to physically expel bacteria from the sulcus (Frank and Cimasoni, 1972; Charon et al., 1982; Delima and Van Dyke, 2003). The flow rate and composition of GCF reflect the health of the immediate periodontal microenvironment. For example, the GCF flow rate is ∼30-fold higher in periodontal pockets compared to healthy sulci, suggesting that GCF flow increases as a host defense mechanism in response to a greater bacterial load (Goodson, 2003). The molecular constituents of the GCF have been extensively studied as potential markers of periodontal health or disease (McCulloch, 1994; Barros et al., 2016). Previous studies have correlated periodontal disease severity with GCF levels of collagenase (Golub et al., 1976), aspartate aminotransferase, a marker for cell death (Sheth and Verma, 2011) and beta-glucoronidase, a marker for neutrophil degranulation (Sanara et al., 2015). However, further research is required to achieve the still-elusive goal of identifying biomarkers with diagnostic or prognostic value in periodontitis (Armitage, 2004a), for example, a GCF-based marker expressed specifically in patients at risk for disease progression.          Figure 10. Schematic diagram illustrates the origin of gingival crevicular fluid (GCF) and its constituents. Cytokines released by immune cells (e.g. neutrophils and macrophages) recruited to the dento-gingival junction are detectable in the GCF.   20 GCF collection methods The analysis of gingival crevicular fluid (GCF) is a well-established research tool that is reported in over 3000 published articles dating back to 1960. Importantly, GCF is readily collected from clinically healthy gingiva as well as periodontal pockets (Alfano, 1974). Three (3) different methods for GCF collection are described in the literature: (1) gingival washing; (2) collection of GCF on to absorbent filter paper strips; and (3) the use of micropipettes (Griffiths, 2003). The three methods are summarized in Table 3. Table 3. Comparison of three methods for gingival crevicular fluid (GCF) collection.  Gingival washing Paper strips Micropipettes Method The sulcus is washed with an isotonic solution  A paper strip is placed at or inside the entrance of sulcus A micropipette is placed at or inside sulcus entrance; GCF migrates up the tube by capillary action  Advantage(s) Allows maximal harvesting of cells Ease of sample collection Ease of sample collection  Pure, undiluted GCF  Disadvantage(s) Elaborate and time-consuming  GCF fluid is diluted   Site-based analysis is impossible Proteins must be eluted from paper strip  Protein binding to strip  Apparatus (Periotron) required to calculate GCF volume (cost)  Centrifugation is necessary for sample recovery  Intracrevicular washing method To collect GCF by washing, the sulcus or pocket is perfused with an isotonic solution, such as Hank’s balanced salt solution. Oppenheim described a method for gingival washing that  21 employs a custom-made hard acrylic appliance to isolate the gingival tissues from the rest of the mouth (Oppenheim, 1970). A peristaltic pump is then used to rinse the crevicular area from one side to the other for 15 minutes. This method allows for maximal harvesting of non-adherent cells, in addition to soluble GCF components. However, the complexity of this procedure is a major disadvantage. In addition, the washing method collects GCF across multiple sites simultaneously, thus precluding accurate analysis of the GCF composition at individual sites.   Absorbent filter paper strips A considerably faster and simpler method for GCF collection involves the use of absorbent filter paper strips inserted to the base of the pocket or until “minimal resistance is felt” (Brill, 1962). A modification of this method involves placing the paper strip just at the entrance of the crevice to minimize irritation of the sulcus (Loe and Holm-Pedersen, 1965). While GCF collection by paper strips is technically straightforward, the fluid and associated analytes must then be eluted off of the paper strip in a separate step. It should also be noted that the GCF proteins may become permanently bound to the paper strips (Johnson et al., 1999). Moreover, calculating the concentration of specific molecules in a given sample requires an accurate determination of the sample volume. This is achievable with the Periotron®, an electronic device that calculates the GCF sample volume based on measurements of the electrical capacitance of the GCF-embedded paper strip (Ciantar and Caruana, 1998). While the Periotron® allows for accurate determinations of GCF volume (Golub et al., 1984; Almas et al., 2003; Mokeem et al., 2014), the cost of this additional armamentarium may present a disadvantage for some investigators.   22 !"#$%&"&'(')Capillary tubing or micropipettes A third method for collecting GCF involves the use of glass micropipettes or capillary tubes. The micropipette is placed at the entrance of the gingival crevice, allowing the GCF to migrate up into the tube by capillary action (Fig. 11). In contrast to the other 2 methods described, the use of micropipettes yields an undiluted GCF sample that does not require elution from any surface. The use of tubes of known internal diameter and length allow for accurate determinations of GCF volume (Mann, 1963; Kaslick et al., 1968) by simply measuring the distance migrated by the GCF (Fig. 11) (Sueda et al., 1969). Since the length and total volume capacity of the tube are known, one can then accurately calculate the sample volume (Griffiths, 2003). The GCF is recovered from the micropipette by centrifugation into a clean microfuge (“Eppendorf”) tube.          Figure 11. Left: photograph depicting GCF collection by the micropipette method. Center: illustration depicts the migration of GCF up the pipette (arrow) via capillary action. Right: the volume of GCF collected is calculated based on the length of fluid migration into the tube of known diameter.   23 Caveats of GCF sample collection The three major sources of contamination while collecting GCF are blood, saliva and dental plaque (Griffiths, 2003). Samples visibly contaminated with blood (Fig. 12) are normally discarded. Saliva contamination can be prevented by isolating the sites to be sampled with cotton rolls, and gently air-drying the area (Fig. 12). As an additional quality control measure against saliva contamination, GCF samples can be analyzed for the presence of the salivary enzyme alpha-amylase (Griffiths et al., 1992). Finally, fluids present in dental plaque can also contaminate GCF samples (Stoller et al., 1990; Griffiths et al., 1992; D'Aoust and Landry, 1994) Supragingival dental plaque should therefore be gently removed with a curette prior to sampling (Fig. 12).    Figure 12. Left: Blood contamination is typically obvious at the time of collection; samples should also be double-checked prior to laboratory analysis (arrow). Center: To prevent saliva contamination, sites to be sampled are isolated with cotton rolls and suction. Right: Supragingival plaque is gently removed with a curette.  Since GCF collection typically yields small volumes from any single site, sampling times are sometimes extended to amplify the yield of GCF (Griffiths, 2003). However, the prolonged presence of a sampling device in the gingival sulcus can introduce artifacts into the GCF (Curtis  24 et al., 1988). For example, the abnormal presence of immunoglobulins (IgM) was detected in GCF samples that were harvested over long periods of time (Griffiths et al., 1997). The authors concluded that the prolonged sampling induces an inflammatory response, resulting in the influx of IgM into the GCF. Therefore, GCF sampling times should be minimized to avoid introducing artifacts into the GCF sample. Fortunately, the availability of highly sensitive laboratory assays can largely compensate for limitations imposed by small sample volumes.  Laboratory methods for GCF analysis The protein constituents of the GCF can be quantified by Western blotting, also known as immunoblotting (Overall et al., 1991; Ingman et al., 1996; Golub et al., 1997; Kiili et al., 2002; Soell et al., 2002; Euzebio Alves et al., 2013). Western blotting is a universally-employed molecular biology technique used to detect proteins within a biological mixture, such as a cell lysate or GCF. Proteins in the GCF sample are separated based on size by electrophoresis and transferred (blotted) on to a membrane that is then probed with an antibody against the target protein (Mahmood and Yang, 2012). Although inexpensive, the relative lack of sensitivity of this method is a significant disadvantage when detecting proteins in low-volume GCF samples. A much more sensitive method to quantify GCF proteins is the enzyme-linked immunosorbent assay, or ELISA (Lee et al., 1995; Ingman et al., 1996; Engebretson et al., 1999; Gamonal et al., 2000a; Mogi et al., 2004; Bostanci et al., 2007; Gan and Patel, 2013). In this method, GCF samples are incubated on surfaces pre-coated with an antibody against the target protein (Gan and Patel, 2013). The bound antigen-antibody complexes emit a colorimetric signal whose intensity is directly proportional to the concentration of the antigen in the GCF sample.  25 The high sensitivity of this assay allows the precise quantification of GCF proteins, even those present in low amounts (Gan and Patel, 2013). Statement of the problem, aim and hypothesis Aim: Evaluate the association between platelets and periodontal inflammation by comparing platelet recruitment and activation in healthy and inflamed periodontium. Hypothesis and rationale: I hypothesized that local and systemic concentrations of platelet factor 4 (PF4) would be elevated during periodontal inflammation. The previously documented pro-inflammatory functions of PF4, combined with its specificity to platelets, made PF4 an ideal choice as a marker of platelet activation. This study is the first to directly evaluate the role of a platelet-specific cytokine in the context of human periodontitis, from both a local and systemic perspective.  Summary of key findings: I studied gingival crevicular fluid (GCF) and platelet samples obtained from patients with gingivitis, periodontitis as well as healthy controls. I report that both gingivitis and periodontitis are characterized by increased platelet recruitment to the periodontium. Moreover, PF4 is markedly more abundant in the GCF of periodontitis sites, but not in the GCF of gingivitis or healthy sites. Further, platelets isolated from periodontitis patients store and secrete more PF4 in response to stimulation with LPS from the periodontal pathogen Porphyromonas gingivalis.  STATEMENT OF THE PROBLEM: The role of platelets in the pathogenesis of periodontal disease is undefined, despite considerable evidence that platelets contribute to chronic inflammation.    26            Chapter Two: Chronic periodontitis is associated with platelet factor 4 (PF4)                           secretion 27 Materials and methods  Recruitment of human subjects for collection of gingival crevicular fluid (GCF) All subjects were recruited from the clinics at the Faculty of Dentistry, University of British Columbia and from local private dental practices (North Vancouver, BC and Surrey, BC, Canada). Approval for GCF sample collection was obtained from the University of British Columbia Clinical Research Ethics Board (CREB). Written informed consent was obtained from each subject before enrolment in the study. To be included, participants needed to be in good general health. Exclusion criteria included smoking, systemic diseases, pregnancy, the use of nonsteroidal inflammatory drugs, the use of systemic antibiotics in the past 6 months and periodontal therapy in the past 6 months. Human donors of gingival crevicular fluid (GCF) were recruited separately from blood donors.  Clinical parameters for collection of gingival crevicular fluid (GCF) Clinical data was obtained from potential sampling sites according to three parameters: (1) the degree of gingival inflammation, based on the visual Modified Gingival Index (MGI) scoring system (Lobene et al., 1989); (2) the presence or absence of bone loss, as determined from dental radiographs; and (3) probing depth (PD), the distance between the gingival margin and the base of the periodontal pocket or sulcus. Based on these data, sites for GCF harvesting were classified as follows:  1. Periodontally healthy: sites with no sign of gingival inflammation (MGI score=0), no radiographic evidence of alveolar bone loss and PD≤3 mm.  28 2. Gingivitis: sites with visible gingival inflammation (MGI≥1) but no radiographic evidence of alveolar bone loss and PD<5 mm. 3. Periodontitis: sites with periodontal pocketing (PD≥5 mm) and alveolar bone loss.  Collection of gingival crevicular fluid (GCF) For GCF collection, the initial site selection was based on visual clinical assessment and information obtained from existing patient records (Fig. 13). To avoid trauma to the periodontal tissues, we refrained from probing the sites prior to GCF harvesting. The previously documented pocket depths were verified by probing the sites after GCF collection. All sampling sites were isolated with cotton rolls to prevent saliva contamination. Supra-gingival plaque was gently removed and the area was dried with a gentle air stream. GCF was collected via capillary action using a microcapillary tube (Drummond Scientific, Broomall, PA). The microcapillary tube was inserted less than 1 mm into the gingival crevice to minimize tissue irritation. Samples with visible blood or plaque contamination were discarded. Immediately following the GCF collection, the probing depths of the corresponding sites were re-measured to ensure appropriate sample classification. The volume of GCF collected was calculated by measuring the length of the microcapillary tube occupied by GCF. The GCF was removed from the microcapillary tube by centrifugation and diluted at a 1:50 ratio with phosphate buffered saline (PBS) supplemented with a protease inhibitor cocktail. Samples were stored at -20oC until analysis. The samples were visually re-inspected for contamination just prior to laboratory analysis. The absence of blood contamination by visual assessment was validated using an enzyme-linked immunosorbent assay (ELISA) for hemoglobin content (Abcam, Cambridge, MA, USA).   29 GCF analysis To quantify local platelet recruitment in the periodontium, cells in the diluted GCF samples were fixed with 2% paraformaldehyde and stained for 30 minutes with a fluorescein isothiocyanate (FITC)-conjugated antibody against CD42a (Beckman-Coulter, Mississauga, ON). The GCF suspension was centrifuged onto a cytospin preparation and analyzed with a Zeiss spinning disk confocal microscope. Confocal images were processed using SlideBook software (Intelligent Imaging Innovations, Denver, CO). For each sample, platelets were counted in at least 15 fields of view. To determine the concentrations of platelet glycoprotein IIbIIIa (GPIIbIIIa) and platelet factor 4 (PF4) in the GCF samples, enzyme-linked immunosorbent assay (ELISA) kits were used in accordance with manufacturer’s instructions (Abcam, Cambridge, MA, USA and R&D Systems, Minneapolis, MN, USA).   Recruitment of blood donors and clinical parameters for blood collection Peripheral venous blood was obtained from fifteen (15) systemically healthy dental patients with approval obtained from the University of British Columbia Clinical Research Ethics Board (CREB) and informed consent in accordance with the Declaration of Helsinki. The subjects were classified as follows: 1. Healthy periodontium (n=7): patients showed no sign of gingival inflammation (MGI score=0) and no radiographic evidence of alveolar bone loss. 2. Gingivitis (n=4): patients with visible gingival inflammation (MGI≥1) but no radiographic evidence of alveolar bone loss and no PD>4 mm. 3. Generalized severe periodontitis (n=4): patients with clear radiographic evidence of alveolar bone loss and periodontal pocketing (PD≥5 mm) at a minimum of 30% of sites.  30 The exclusion criteria that were applied to GCF donors were also applied to potential blood donors. The detailed periodontal characteristics of the blood donors are summarized in Table 4.  Human platelet preparation Platelets were isolated by sequential centrifugation of whole blood and the resultant platelet-rich plasma. The platelet pellet was washed twice with a washing buffer (140 mM NaCl, 5 mM KCl, 12 mM trisodium citrate, 10 mM glucose, 12.5 mM sucrose, pH 6.0) supplemented with prostaglandin-1 (Sigma). Washed platelets were resuspended in resuspension buffer (10 mM HEPES, 140 mM NaCl, 3 mM KCl, 0.5 mM MgCl2 , 5 mM NaHCO3, 10 mM glucose, pH 7.4) containing apyrase (Sigma) and allowed to rest for 30 minutes at 37oC prior to use.   Measurement of LPS-induced release of PF4 For quantification of PF4 release, resting platelets were activated over a time course ranging from 30 seconds to 30 minutes with lipopolysaccharide (LPS) from Porphyromonas gingivalis (Invivoven, San Diego, CA). The reactions were stopped by centrifugation at 4oC, and the ensuing pellet (cell fraction) and supernatants (releasate fraction) were separated. The corresponding pellets were solubilized in lysis buffer. The concentrations of PF4 in the cell and releasate fractions were determined by ELISA as described above.   Statistical analysis A one-way analysis of variance (ANOVA) and Bonferroni post-hoc multiple comparison tests were used to assess the effect of periodontal status (healthy, gingivitis, periodontitis) on the various tested parameters. Statistical significance was set at p<0.05.  31 Results  To evaluate the local recruitment of platelets to the periodontium, we analyzed gingival crevicular fluid (GCF) samples, which is a well-established approach to analyzing cells and host-and pathogen-derived products released in the periodontium (Delima and Van Dyke, 2003; Armitage, 2004a; Buduneli and Kinane, 2011). To exclude the possibility of blood contamination, any visibly blood-contaminated GCF samples were discarded. As an additional quality control measure, we validated our visual assessment by quantifying hemoglobin levels (ELISA, Abcam) in GCF samples with and without visible blood contamination. Visibly contaminated GCF samples had a mean hemoglobin concentration of 133.9 ± 2.88 ng/mL (mean ± SD, n=6) but there was no detectable hemoglobin in the samples that passed the visual assessment test. Similarly, we used a colorimetric amylase detection kit (Abcam) to objectively exclude the possibility of saliva contamination in the GCF. Amylase levels were 26.5 ± 2.88 nmol/well (mean ± SD, n=6) in saliva-spiked GCF samples but was not detectable in samples collected with cotton roll isolation.  Confocal microscopy of cytospin preparations revealed the presence of platelets in the gingival crevicular fluid (GCF) obtained from healthy control sites (Fig. 14A), sites with gingivitis (Fig. 14B) as well as periodontal pockets (Fig. 14C). Microscopic counts of platelet numbers showed that platelets were ∼3 times more abundant in gingivitis sites relative to healthy control sites (p<0.0001), and were further elevated in periodontal pockets (Fig. 14D). As a complementary approach to platelet quantification, we used ELISA to quantify the platelet-specific glycoprotein   32 IIbIIIa (GPIIbIIIa) receptor on the platelet surface (Watson et al., 2005). There was a ∼3-fold elevation (p<0.0001) in the concentration of GPIIbIIIa in sites with gingivitis (n=34) compared to healthy control sites (n=29). As was observed in the cytospin preparations, the highest levels GPIIbIIIa were found in periodontal pockets (n=22) (Fig. 14E). The concordant results from these 2 assays indicate that platelets are recruited to sites of periodontal inflammation.  To assess the activation status of platelets recruited in the periodontium, we quantified the concentration of platelet factor 4 (PF4) in GCF samples obtained at sites with healthy periodontium, gingivitis and periodontitis. There was no difference (p>0.05) in the concentration of PF4 between healthy control sites and gingivitis sites (Fig. 15A). However, periodontal pockets harbored ~20 times more PF4 than GCF from the other 2 groups (p<0.0001) (Fig. 15A). We then stratified these data according to different ranges of PF4 concentration [PF4]GCF (Fig. 15B). Notably, none of the periodontally healthy (n=25) and gingivitis sites (n=20) had a [PF4]GCF in excess of 0.5 ng/mL. In contrast, the [PF4]GCF exceeded 0.5 ng/mL in 59% of periodontal pockets (Fig. 15B). These data indicate that platelets are preferentially activated during periodontitis but not gingivitis, despite being recruited in comparable numbers in both disease states.  Since PF4 levels were locally elevated at individual periodontal pockets, we then set out to determine whether platelets would be functionally different in patients with generalized severe chronic periodontitis (SP), compared to controls. The circulating concentration of PF4 was ~2 times higher (p<0.05) in patients with generalized SP, compared to patients in the periodontally healthy and gingivitis groups (Fig. 16A). In addition, resting platelets isolated from the whole   33 blood of SP patients contained more PF4 than platelets from the other 2 patient groups although this was not statistically significant (p>0.05) (Fig. 16B).  Published evidence indicates that platelets are activated by periodontal pathogens (Li et al., 2008; Nylander et al., 2008; Assinger et al., 2011; Yu et al., 2011). To determine whether platelets from SP patients released more PF4 in the context of periodontitis, we stimulated the isolated platelets in vitro with lipopolysaccharide (LPS) from Porphyromonas gingivalis, a pathogen central to the etiology of periodontitis (Holt and Ebersole, 2005a). Secretion of PF4 was observed in all 3 patient groups (healthy, gingivitis, SP) following LPS stimulation (Fig. 17A). Notably, the unstimulated release of PF4 was highest in platelets from the SP group, suggesting that severe periodontitis is associated with an ongoing, agonist-independent release of PF4. In addition, while the PF4 release from platelets in the healthy and gingivitis groups plateaued after 1 minute of LPS stimulation, PF4 release in the SP group continued to rise over the 30-minute post-stimulation period (Fig. 17A). Finally, when the secretion data are expressed in terms of percentage of total PF4 content (Fig. 17B), the platelets from the severe periodontitis group release a greater proportion of their total PF4 content in response to P. gingivalis LPS. Taken together, these data show that platelets isolated from patients with generalized severe periodontitis contain more PF4 and are more responsive to LPS stimulation than platelets isolated from periodontally healthy or gingivitis subjects.       34     Table 4. Periodontal characteristics of blood donors                                  Healthy (n=7)           Gingivitis (n=4)         Periodontitis (n=4)  Age (mean ± SD)                  43.4 ± 7.8                      47.8 ± 11.7      51.2 ± 13.5    Mean PD (mm)                      2.5 ± 0.8     2.3 ± 0.9      5.0 ± 2.1   PD range (mm)     1-4         1-4              1-15  PD≤4 mm (% sites)                100         100                      48  5mm<PD<7 mm (% sites)                                     0           0             41  PD≥7 mm (% sites)       0           0            11  BOP (% ± SD)            1.6 ± 1.5   28.9 ± 6.1    69.0 ± 24.6  PI (% ± SD)                           0.4 ± 1.1   16.2 ± 1.5    86.5 ± 16.3   Legend:  SD: Standard deviation PD: Probing depth BOP: Bleeding on probing PI: Plaque index   A. INITIAL SITE CLASSIFICATION Healthy controls Gingivitis Periodontitis NO YES YES NO Presence of gingival inflammation? Presence of bone loss(determined by radiographs? B. GINGIVAL CREVICULAR FLUID (GCF)                         COLLECTION C. PROBING DEPTH (PD) MEASUREMENT         FINAL SAMPLE CLASSIFICATION Healthy controls: •  No inflammation              AND •  PD!3 mm Gingivitis: •  No bone loss           AND •  PD!4 mm Periodontitis: •  Bone loss          AND •  PD"5 mm Informed consent Assessment for contamination D. RE-ASSESSMENT FOR CONTAMINATION                LABORATORY ANALYSIS Figure 13. Algorithm for GCF sample collection and classification.  A. After obtaining informed consent, GCF donor sites were initially triaged based on the presence or absence of gingival inflammation; sites with no visible gingival inflammation were assigned to the healthy control group. Sites with gingival inflammation but no bone loss were assigned to the gingivitis group. Sites with gingivitis and bone loss were assigned to the periodontitis group.  B. To avoid tissue trauma, periodontal probing was avoided until after GCF harvesting. Following sample collection, the GCF was visually inspected for contamination.  C. Probing depth was then measured to ensure classification of the GCF samples into the appropriate groups.  D. Following a second independent visual inspection, samples were subjected to laboratory analysis. 35 Health Gingivitis A. B. C. Perio 0 2 4 6 8 10 12 14 16 18 Mean platelet counts in GCF (cytospin) Healthy Gingivitis Periodontitis E. D. *	   *	  0.0 1.0 2.0 3.0 4.0 5.0  !!GPIIbIIIa concentration in GCF (ng/mL) Health Gingivitis Periodontitis *	   *	  Figure 14. Platelets are recruited to sites of periodontal inflammation.  A-C. Confocal micrographs of cytospin preparations illustrate the presence of platelets in the gingival crevicular fluid (GCF) obtained from healthy periodontium (A), a site with gingivitis (B) and a periodontal pocket (C). Cells were stained with a FITC-conjugated antibody against the platelet-specific marker CD42a. Bar=10 µm.  D. Histogram compares the relative recruitment of platelets in the GCF of periodontally healthy sites (white bar, n=3), sites with gingivitis (grey bar, n=3) and periodontitis sites (black bar, n=3). For each cytospin preparation, the number of platelets was counted in 15 fields field of view. Data are expressed as mean ± SEM. *, p<0.0001, based on Bonferroni multiple comparison tests.  E. Histogram illustrates the concentration of glycoprotein IIbIIIa (GPIIbIIIa) in the GCF of periodontally healthy sites (white bar, n=29), sites with gingivitis (grey bar, n=34) and periodontitis sites (black bar, n=22). GPIIbIIIa levels were determined by enzyme-linked immunosorbent assay (ELISA). Data are expressed as mean ± SEM. *, p<0.0001, based on Bonferroni multiple comparison tests. 36 0.0 0.5 1.0 1.5 2.0  !!PF4 concentration in GCF (ng/mL) Health Gingivitis Periodontitis A. 0 10 20 30 40 50 60 70 80 90  !!Percentage (%) of sites Health Gingivitis Periodontitis B. [PF4]GCF (ng/mL) 0 0 – 0.5 0.5 – 1 > 1 *	  Figure 15. Gingival crevicular fluid (GCF) concentrations of platelet factor 4 (PF4) are elevated in periodontal pockets.  A. Histogram illustrates the mean platelet factor 4 (PF4) concentration in the GCF harvested from periodontally healthy sites (white bar, n=25), sites with gingivitis (grey bar, n=20) and periodontitis sites (black bar, n=22). PF4 concentration was determined by ELISA. Data are expressed as mean ± SEM. *, p<0.0001, based on Bonferroni multiple comparison tests.  B. Histogram illustrates the distribution of test sites (healthy, gingivitis, periodontitis) within the various ranges of PF4 concentration ([PF4]GCF).  37 A. 0.0 0.5 1.0 1.5 2.0 2.5  !!PF4 concentration in plasma (relative) Health Gingivitis Periodontitis 0.0 0.5 1.0 1.5  !!Total platelet PF4 content (relative) Health Gingivitis Periodontitis B. *	  Figure 16. Circulating PF4 and platelet loading of PF4 is elevated in patients with generalized severe chronic periodontitis.  A. Histogram illustrates the relative circulating levels of PF4 in the platelet-poor plasma of patients with healthy periodontium (white bar, n=7), patients with gingivitis (grey bar, n=4) and patients with generalized severe chronic periodontitis (black bar, n=4). Data are expressed as mean ± SEM, with patients from healthy periodontium set at 1.  B. Histogram illustrates the total PF4 content in platelets obtained from patients with healthy periodontium (white bar, n=7), patients with gingivitis (grey bar, n=4) and patients with generalized severe chronic periodontitis (black bar, n=4). Data are expressed as mean ± SEM, with platelets from periodontally healthy subjects set at 1.  38 0.0 10.0 20.0 30.0 40.0 50.0 60.0 0 0.5 1 2 5 15 30 PF4 release (ng/mL)  LPS stimulation time (minutes) Healthy Gingivitis Periodontitis A. B. 0.0 2.0 4.0 6.0 8.0 10.0 12.0 0 0.5 1 2 5 15 30 PF4 release (percent total)  LPS stimulation time (minutes) Healthy Gingivitis Periodontitis **	   **	  **	   ***	  ***	  *	  *	  n.s. *	  n.s. Figure 17. LPS-induced PF4 release is amplified from platelets isolated from patients with generalized severe chronic periodontitis.  A. Line graph illustrates the LPS-induced release of PF4 from equal numbers of platelets isolated from the blood of patients with healthy periodontium (closed circles, n=7), patients with gingivitis (open circles, n=4) and patients with generalized severe chronic periodontitis (open triangles, n=4). Data are expressed as mean ± SEM. *, p<0.05; **, p<0.01; ***, p<0.001; n.s., not significant, based on Bonferroni multiple comparison tests.  B. Line graph illustrates the LPS-induced release of PF4, expressed as percent of total PF4 content, from equal numbers of platelets isolated from the blood of patients with healthy periodontium (closed circles, n=7), patients with gingivitis (open circles, n=4) and patients with generalized severe chronic periodontitis (open triangles, n=4). Data are expressed as mean ± SEM.  39 PERIODONTITIS C. Bone Biofilm Platelets ++ Sulcus Platelets Bone B. Gingivitis A. Periodontal health Activated platelets  +++ Bone loss Gram - Biofilm LPS ++ Periodontitis Increased [PF4] Neutrophils !Adhesion to EC !Degranulation!!Monocytes !TNF secretion !ROS !Cytokine production !!2. ![PF4] in pocket Apical migration of the JE 1. 3. Activated platelets +++ Figure 18. Proposed model outlining platelet recruitment and PF4 release in the context of periodontitis.  A. Diagram depicts the cross section of the dento-gingival junction (tooth/sulcus in a healthy periodontium and the relative absence of LPS challenge. Inset (bottom-right) depicts platelets (yellow) exiting the systemic circulation.  B. During gingivitis induced by bacterial plaque (green), increased numbers of platelets are recruited to the dento-gingival junction (red arrow) but remain generally quiescent and do not release significant quantities of PF4.  C. During periodontitis, the gram-negative, LPS-laden biofilm (purple) provides continued stimulation of the recruited platelets (1), thus inducing the release of PF4 (2), which potentiates neutrophil and monocyte activity thus promoting periodontal tissue degradation. Bone degradation and apical migration of the junctional epithelium (JE) occur. Inset: The elevated plasma concentration of PF4 in the systemic circulation likely accentuates activation of local leukocytes. (3) Severe periodontal infection likely provides a source of periodontal pathogens and LPS in the systemic circulation, thus creating a feedback mechanism (blue arrow) that could maintain elevated levels of circulating PF4.  40   41 Discussion  Periodontitis is a highly prevalent and destructive inflammatory disease, and the molecular determinants of its pathogenesis remain undefined. Current evidence supports the existence of a general association between platelet count and activation and periodontitis (Nicu et al., 2009b; Papapanagiotou et al., 2009; Al-Rasheed, 2012b; Kumar et al., 2014). However, the present study is the first to investigate a specific role for platelet factor 4 (PF4), which is the major constituent of platelet granules (Lambert et al., 2007). Here we demonstrated that local and systemic elevations of PF4 are correlated with periodontitis in humans. This conclusion is based on our finding that periodontal pockets contained ∼20 times more PF4 than gingival sulci associated with healthy periodontium or gingivitis. Moreover, platelets isolated from patients with generalized severe periodontitis stored and secreted more PF4 than platelets from periodontally healthy or gingivitis subjects. In addition, basal circulating concentrations of PF4 were doubled in patients with severe periodontitis relative to controls. This is the first study analyze PF4 concentration in the context of periodontal health and disease.   Platelets are recruited to sites of gingival inflammation Our analysis of gingival crevicular fluid (GCF) with 2 complementary approaches indicates that platelets are recruited to the dento-gingival junction during gingival inflammation. Since blood contamination was excluded as a source of platelets in the GCF, we conclude that platelets exit the circulation at sites of gingival inflammation. This is consistent with early reports that platelets respond to chemotactic signals (Lowenhaupt, 1978; Lowenhaupt, 1982; Lowenhaupt et al., 1982) and that platelets enter inflamed tissues by diapadesis and extravasation (Beasley et al.,   42 1989; Feng et al., 1998). The underlying mechanism for platelet recruitment to the periodontium is unclear. One possibility is that the clinical onset of gingivitis is accompanied by the expression of an unidentified bacteria- or host-derived platelet chemokine. Alternatively, since periodontal inflammation is characterized by marked neutrophil influx (Hajishengallis et al., 2014), it is plausible that platelets are recruited in tandem with neutrophils given the extensive and well-documented crosstalk between the two cell types (Li et al., 2000; Ghasemzadeh and Hosseini, 2013; Page and Pitchford, 2013).  PF4 is preferentially secreted during periodontitis A striking finding from our study was the ∼20-fold elevation of PF4 concentration in periodontitis sites relative to gingivitis sites, despite there being roughly equivalent platelet recruitment in both conditions. This finding indicates that platelet activation is specifically accentuated in advanced periodontal lesions. This may be explained by the relative abundance of gram-negative pathogens (Holt and Ebersole, 2005a) in advanced periodontitis lesions relative to early gingivitis lesions. Notably, platelets express toll-like receptor 4 (TLR4), which recognizes the lipopolysaccharide (LPS) component of gram-negative periodontal pathogens such as Porphyromonas gingivalis (Andonegui et al., 2005; Cognasse et al., 2008; Zhang et al., 2009b). In addition, direct platelet activation by periodontal pathogens, including P. gingivalis, is well documented (Li et al., 2008; Nylander et al., 2008; Assinger et al., 2011; Yu et al., 2011). The local abundance of PF4 may also be explained by the presence of other known platelet agonists in periodontitis lesions, such as thromboxane (Dewhirst et al., 1983; Bons-Sicard et al., 1998) and platelet-activating factor (McManus and Pinckard, 2000; Emingil et al., 2001b) that could potentiate platelet activation along with LPS.    43  There are several plausible explanations to support a role for PF4 in the progression of periodontitis. For example, PF4 promotes neutrophil degranulation (Bebawy et al., 1986; Petersen et al., 1996; Vandercappellen et al., 2011), which contributes to tissue proteolysis in periodontitis lesions (Klebanoff, 2005). Moreover, PF4 promotes monocyte survival and secretion of tumor necrosis factor-alpha (TNF-α) (Scheuerer et al., 2000; Srivastava et al., 2010), a pro-inflammatory cytokine that in turn stimulates the production of collagen-degrading matrix metalloproteinases (MMPs) by gingival fibroblasts (Domeij et al., 2002). In addition, PF4 induces the formation of reactive oxygen species (ROS) in macrophages (Pervushina et al., 2004) that also contribute to degradation of the periodontal tissues (Waddington et al., 2000; Dahiya et al., 2013). In this context, our findings are consistent with the notion that PF4 propagates the pro-inflammatory and tissue-degrading activities of neutrophils and monocytes in the periodontium (Fig. 6).    Periodontitis is correlated with systemic levels of circulating PF4 We found platelet PF4 content and circulating PF4 levels to be elevated in patients with generalized severe periodontitis, consistent with previous reports recording increased platelet activation in periodontitis patients (Nicu et al., 2009b; Papapanagiotou et al., 2009). Notably, in our study, platelets from the periodontitis group secreted a higher percentage of their total PF4 content in response to LPS, suggesting that their platelets are also abnormally reactive to LPS stimulation. In addition, oral bacteria enter the bloodstream following innocuous procedures such as toothbrushing (Lockhart et al., 2008). It is therefore plausible that the platelets of untreated severe periodontitis patients are subjected to continuous LPS stimulation, thus creating a   44 feedback loop that would maintain elevated PF4 levels in the systemic circulation while further exacerbating inflammation and tissue degradation in the periodontium (Fig. 18).   PF4 is also implicated in the pathogenesis of atherosclerosis, an inflammatory vascular disease characterized by the formation of plaques along the arterial wall. The putative relationship between periodontitis and atherosclerosis has been extensively studied (Bartova et al., 2014b; Teeuw et al., 2014). Notably, PF4 promotes the adhesion of monocytes to the endothelium and their eventual differentiation into lipid-laden macrophages that form the core of the atherosclerotic plaque (Gawaz et al., 2005; Aidoudi and Bikfalvi, 2010a; Gleissner, 2012). In this context, our discovery of increased PF4 levels in severe periodontitis may provide additional evidence linking the pathogenesis of the two diseases.   A limitation of our study was the small number of subjects available for the blood- and platelet-based analyses. This was largely due to our strict inclusion criteria that limited the periodontitis group to patients with generalized severe disease in the absence of any other contributing factors such as smoking. However, this shortcoming was mitigated by the large differences observed between the test groups as well as by the concordance of the platelet-based data with the results of the GCF studies that were conducted over much larger sample sizes. Another shortcoming is that our cross-sectional data do not permit the evaluation of PF4 as a causal factor in the initiation or progression of periodontitis.  Our finding that PF4 was largely absent from the GCF of healthy and gingivitis sites invites speculation that PF4 may contribute to the transition between gingivitis to periodontitis.   45 Conceivably, PF4 could represent a biomarker for periodontal sites at risk for disease progression. Future prospective, longitudinal studies could also query the significance of circulating PF4 levels as a novel tool for assessing individual susceptibility to periodontitis and/or atherosclerosis.    46          Chapter Three: Conclusions and Future Directions  47 Conclusions: Our study identifies a novel role for platelets in the context of periodontal disease pathogenesis. While previously published data have suggested a general correlation between systemic platelet reactivity and periodontal status (Nicu et al., 2009a; Papapanagiotou et al., 2009), our study is the first to employ molecular probes for platelet-specific molecules (CD42, GPIIbIIIa, PF4) to demonstrate in situ platelet recruitment and activation in the inflamed periodontium.   Directions for future research: 1. Our finding of increased platelet factor 4 (PF4) levels in the gingival crevicular fluid in periodontitis, but not gingivitis, lesions raises the interesting possibility that PF4 may promote the shift from gingivitis to periodontitis. While this cannot be ascertained from our cross-sectional study, future prospective studies could measure both local (GCF) and systemic (plasma) concentrations of PF4 over time to determine whether higher concentrations of PF4 confer an increased risk for subsequent periodontal breakdown.  2. The hypothesis that platelet activation induces periodontitis could be tested with an experimental periodontitis model, for example, using thrombocytopenic mice and controls. 3. In patients with generalized severe periodontal disease, it would be of interest to determine whether successful periodontal therapy causes a systemic reduction in circulating PF4. 4. A limitation of our study was the evaluation of only one molecule (PF4) in the gingival crevicular fluid. Future studies could employ multiplex ELISA assay arrays capable of analyzing the concentration of multiple analytes simultaneously (Shimada et al., 2013). This   48 approach, while costly, could provide insight into the concentration of platelet-derived cytokines relative to those cytokines derived from other cell types.    49 Bibliography:    (1996). Proceedings of the 1996 World Workshop in Periodontics. Lansdowne, Virginia, July 13-17, 1996. Ann Periodontol 1, 1-947.  Aidoudi, S. and Bikfalvi, A. (2010a). Interaction of PF4 (CXCL4) with the vasculature: a role in atherosclerosis and angiogenesis. Thrombosis and haemostasis 104, 941-8.  Al-Rasheed, A. (2012a). Elevation of white blood cells and platelet counts in patients having chronic periodontitis. Saudi Dent J 24, 17-21.  Alfano, M. C. (1974). The origin of gingival fluid. J Theor Biol 47, 127-36.  Almas, K., Al-Lazzam, S. and Al-Quadairi, A. (2003). The effect of oral hygiene instructions on diabetic type 2 male patients with periodontal diseases. J Contemp Dent Pract 4, 24-35.  Andonegui, G., Kerfoot, S. M., McNagny, K., Ebbert, K. V., Patel, K. D. and Kubes, P. (2005). Platelets express functional Toll-like receptor-4. Blood 106, 2417-23.  Andrian, E., Grenier, D. and Rouabhia, M. (2004). In vitro models of tissue penetration and destruction by Porphyromonas gingivalis. Infect Immun 72, 4689-98.  Armitage, G. C. (1999). Development of a classification system for periodontal diseases and conditions. Ann Periodontol 4, 1-6.  Armitage, G. C. (2004a). Analysis of gingival crevice fluid and risk of progression of periodontitis. Periodontol 2000 34, 109-19.  Armitage, G. C. (2004b). The complete periodontal examination. Periodontol 2000 34, 22-33.  Armitage, G. C. (2004c). Periodontal diagnoses and classification of periodontal diseases. Periodontol 2000 34, 9-21.  Assinger, A., Buchberger, E., Laky, M., Esfandeyari, A., Brostjan, C. and Volf, I. (2011). Periodontopathogens induce soluble P-selectin release by endothelial cells and platelets. Thrombosis research 127, e20-6.  Attstrom, R. (1970). Presence of leukocytes in crevices of healthy and chronically inflamed gingivae. J Periodontal Res 5, 42-7.  Barros, S. P., Williams, R., Offenbacher, S. and Morelli, T. (2016). Gingival crevicular fluid as a source of biomarkers for periodontitis. Periodontol 2000 70, 53-64.  Bartold, P. M. and Van Dyke, T. E. (2013). Periodontitis: a host-mediated disruption of microbial homeostasis. Unlearning learned concepts. Periodontol 2000 62, 203-17.  Bartova, J., Sommerova, P., Lyuya-Mi, Y., Mysak, J., Prochazkova, J., Duskova, J., Janatova, T. and Podzimek, S. (2014a). Periodontitis as a risk factor of atherosclerosis. J Immunol Res 2014, 636893.  Beasley, R., Roche, W. R., Roberts, J. A. and Holgate, S. T. (1989). Cellular events in the bronchi in mild asthma and after bronchial provocation. The American review of respiratory disease 139, 806-17.  Bebawy, S. T., Gorka, J., Hyers, T. M. and Webster, R. O. (1986). In vitro effects of platelet factor 4 on normal human neutrophil functions. Journal of leukocyte biology 39, 423-34.  Bender, A., Zapolanski, T., Watkins, S., Khosraviani, A., Seiffert, K., Ding, W., Wagner, J. A. and Granstein, R. D. (2008). Tetracycline suppresses ATP gamma S-induced CXCL8 and CXCL1 production by the human dermal microvascular endothelial cell-1 (HMEC-  50 1) cell line and primary human dermal microvascular endothelial cells. Exp Dermatol 17, 752-60.  Berglundh, T. and Donati, M. (2005). Aspects of adaptive host response in periodontitis. J Clin Periodontol 32 Suppl 6, 87-107.  Bickel, M. (1993). The role of interleukin-8 in inflammation and mechanisms of regulation. J Periodontol 64, 456-60.  Bons-Sicard, C., Choquet, A. and Escola, R. (1998). Localization and quantification of TXB2 in human healthy and inflammatory gingival mucosa. Journal of periodontal research 33, 27-32.  Bostanci, N., Ilgenli, T., Emingil, G., Afacan, B., Han, B., Toz, H., Atilla, G., Hughes, F. J. and Belibasakis, G. N. (2007). Gingival crevicular fluid levels of RANKL and OPG in periodontal diseases: implications of their relative ratio. J Clin Periodontol 34, 370-6.  Brecx, M. C., Gautschi, M., Gehr, P. and Lang, N. P. (1987). Variability of histologic criteria in clinically healthy human gingiva. J Periodontal Res 22, 468-72. Brill, N. (1962). The gingival pocket fluids. Studies of its occurrence, composition, and effect. Acta Odontol Scand. 20: supplement 32.   Buduneli, N. and Kinane, D. F. (2011). Host-derived diagnostic markers related to soft tissue destruction and bone degradation in periodontitis. Journal of clinical periodontology 38 Suppl 11, 85-105.  Carpenter, G. and Cohen, S. (1979). Epidermal growth factor. Annu Rev Biochem 48, 193-216.  Carvalho, R. S., de Souza, C. M., Neves, J. C., Holanda-Pinto, S. A., Pinto, L. M., Brito, G. A. and de Andrade, G. M. (2010). Effect of venlafaxine on bone loss associated with ligature-induced periodontitis in Wistar rats. J Negat Results Biomed 9, 3.  Carvalho-Filho, P. C., Gomes-Filho, I. S., Meyer, R., Olczak, T., Xavier, M. T. and Trindade, S. C. (2016). Role of Porphyromonas gingivalis HmuY in Immunopathogenesis of Chronic Periodontitis. Mediators Inflamm 2016, 7465852.  Cekici, A., Kantarci, A., Hasturk, H. and Van Dyke, T. E. (2014). Inflammatory and immune pathways in the pathogenesis of periodontal disease. Periodontology 2000 64, 57-80.  Chang, K. M., Lehrhaupt, N., Lin, L. M., Feng, J., Wu-Wang, C. Y. and Wang, S. L. (1996). Epidermal growth factor in gingival crevicular fluid and its binding capacity in inflamed and non-inflamed human gingiva. Arch Oral Biol 41, 719-24.  Charon, J. A., Metzger, Z., Hoffeld, J. T., Oliver, C., Gallin, J. I. and Mergenhagen, S. E. (1982). An in vitro study of neutrophils obtained from the normal gingival sulcus. J Periodontal Res 17, 614-25.  Chaturvedi, R., Gupta, M., Jain, A., Das, T. and Prashar, S. (2015). Soluble CD40 ligand: a novel biomarker in the pathogenesis of periodontal disease. Clin Oral Investig 19, 45-52.  Chen, H., Zheng, P., Zhu, H., Zhu, J., Zhao, L., El Mokhtari, N. E., Eberhard, J., Lins, M. and Jepsen, S. (2010). Platelet-activating factor levels of serum and gingival crevicular fluid in nonsmoking patients with periodontitis and/or coronary heart disease. Clin Oral Investig 14, 629-36.  Ciantar, M. and Caruana, D. J. (1998). Periotron 8000: calibration characteristics and reliability. J Periodontal Res 33, 259-64.   51  Clemetson, K. J. (2011). The role of platelets in defence against pathogens. Hamostaseologie 31, 264-8.  Cognasse, F., Hamzeh-Cognasse, H., Lafarge, S., Delezay, O., Pozzetto, B., McNicol, A. and Garraud, O. (2008). Toll-like receptor 4 ligand can differentially modulate the release of cytokines by human platelets. British journal of haematology 141, 84-91.  Coimbra, L. S., Rossa, C., Jr., Guimaraes, M. R., Gerlach, R. F., Muscara, M. N., Spolidorio, D. M., Herrera, B. S. and Spolidorio, L. C. (2011). Influence of antiplatelet drugs in the pathogenesis of experimental periodontitis and periodontal repair in rats. J Periodontol 82, 767-77.  Coimbra, L. S., Steffens, J. P., Muscara, M. N., Rossa, C., Jr. and Spolidorio, L. C. (2014). Antiplatelet drugs reduce the immunoinflammatory response in a rat model of periodontal disease. J Periodontal Res 49, 729-35.  Curtis, M. A., Griffiths, G. S., Price, S. J., Coulthurst, S. K. and Johnson, N. W. (1988). The total protein concentration of gingival crevicular fluid. Variation with sampling time and gingival inflammation. J Clin Periodontol 15, 628-32.  Czapiga, M., Gao, J. L., Kirk, A. and Lekstrom-Himes, J. (2005). Human platelets exhibit chemotaxis using functional N-formyl peptide receptors. Exp Hematol 33, 73-84.  D'Aoust, P. and Landry, R. G. (1994). The effect of supragingival plaque on crevicular fluid measurements. Int Dent J 44, 159-64.  Dahiya, P., Kamal, R., Gupta, R., Bhardwaj, R., Chaudhary, K. and Kaur, S. (2013). Reactive oxygen species in periodontitis. Journal of Indian Society of Periodontology 17, 411-6.  Danese, S., Motte Cd Cde, L. and Fiocchi, C. (2004). Platelets in inflammatory bowel disease: clinical, pathogenic, and therapeutic implications. The American journal of gastroenterology 99, 938-45.  Delima, A. J. and Van Dyke, T. E. (2003). Origin and function of the cellular components in gingival crevice fluid. Periodontol 2000 31, 55-76.  Deo, V. and Bhongade, M. L. (2010). Pathogenesis of periodontitis: role of cytokines in host response. Dent Today 29, 60-2, 64-6; quiz 68-9.  Dewhirst, F. E., Moss, D. E., Offenbacher, S. and Goodson, J. M. (1983). Levels of prostaglandin E2, thromboxane, and prostacyclin in periodontal tissues. Journal of periodontal research 18, 156-63.  Domeij, H., Yucel-Lindberg, T. and Modeer, T. (2002). Signal pathways involved in the production of MMP-1 and MMP-3 in human gingival fibroblasts. European journal of oral sciences 110, 302-6.  Egelberg, J. (1963). Cellular Elements in Gingival Pocket Fluid. Acta Odontol Scand 21, 283-7.  Eke, P. I., Dye, B. A., Wei, L., Slade, G. D., Thornton-Evans, G. O., Borgnakke, W. S., Taylor, G. W., Page, R. C., Beck, J. D. and Genco, R. J. (2015). Update on Prevalence of Periodontitis in Adults in the United States: NHANES 2009 to 2012. J Periodontol 86, 611-22.  Emingil, G., Cinarcik, S., Baylas, H. and Huseyinov, A. (2001a). Levels of platelet-activating factor in gingival crevicular fluid and gingival tissue in specific periodontal diseases. J Periodontol 72, 1032-7.   52  Emingil, G., Cinarcik, S., Baylas, H. and Huseyinov, A. (2001b). Levels of platelet-activating factor in gingival crevicular fluid and gingival tissue in specific periodontal diseases. Journal of periodontology 72, 1032-7.  Engebretson, S. P., Lamster, I. B., Herrera-Abreu, M., Celenti, R. S., Timms, J. M., Chaudhary, A. G., di Giovine, F. S. and Kornman, K. S. (1999). The influence of interleukin gene polymorphism on expression of interleukin-1beta and tumor necrosis factor-alpha in periodontal tissue and gingival crevicular fluid. J Periodontol 70, 567-73.  Engstad, C. S., Lia, K., Rekdal, O., Olsen, J. O. and Osterud, B. (1995). A novel biological effect of platelet factor 4 (PF4): enhancement of LPS-induced tissue factor activity in monocytes. J Leukoc Biol 58, 575-81.  Euzebio Alves, V. T., Bueno da Silva, H. A., de Franca, B. N., Eichler, R. S., Saraiva, L., de Carvalho, M. H. and Holzhausen, M. (2013). Periodontal treatment downregulates protease-activated receptor 2 in human gingival crevicular fluid cells. Infect Immun 81, 4399-407.  Feng, D., Nagy, J. A., Pyne, K., Dvorak, H. F. and Dvorak, A. M. (1998). Platelets exit venules by a transcellular pathway at sites of F-met peptide-induced acute inflammation in guinea pigs. International archives of allergy and immunology 116, 188-95.  Frank, R. M. and Cimasoni, G. (1972). Electron microscopy of acid phosphatase in the exudate from inflamed gingiva. J Periodontal Res 7, 213-25.  Gamonal, J., Acevedo, A., Bascones, A., Jorge, O. and Silva, A. (2000a). Levels of interleukin-1 beta, -8, and -10 and RANTES in gingival crevicular fluid and cell populations in adult periodontitis patients and the effect of periodontal treatment. J Periodontol 71, 1535-45.  Gamonal, J., Bascones, A., Jorge, O. and Silva, A. (2000b). Chemokine RANTES in gingival crevicular fluid of adult patients with periodontitis. J Clin Periodontol 27, 675-81.  Gan, S. D. and Patel, K. R. (2013). Enzyme immunoassay and enzyme-linked immunosorbent assay. J Invest Dermatol 133, e12.  Gawaz, M., Langer, H. and May, A. E. (2005). Platelets in inflammation and atherogenesis. The Journal of clinical investigation 115, 3378-84.  Ghasemzadeh, M. and Hosseini, E. (2013). Platelet-leukocyte crosstalk: Linking proinflammatory responses to procoagulant state. Thrombosis research 131, 191-7.  Gherardi, E. and Stoker, M. (1991). Hepatocyte growth factor--scatter factor: mitogen, motogen, and met. Cancer Cells 3, 227-32.  Gleissner, C. A. (2012). Platelet-derived chemokines in atherogenesis: what's new? Current vascular pharmacology 10, 563-9.  Golijanin, R., Kujundzic, B., Milosavljevic, Z., Milovanovic, D. R., Andjelkovic, Z., Obrenovic, M. and Nikolic, R. (2015). Morphometric analysis of collagen and inflammatory cells in periodontal disease. Vojnosanit Pregl 72, 219-24.  Golub, L. M., Lee, H. M., Greenwald, R. A., Ryan, M. E., Sorsa, T., Salo, T. and Giannobile, W. V. (1997). A matrix metalloproteinase inhibitor reduces bone-type collagen degradation fragments and specific collagenases in gingival crevicular fluid during adult periodontitis. Inflamm Res 46, 310-9.  Golub, L. M., Ramamurthy, N., McNamara, T. F., Gomes, B., Wolff, M., Casino, A., Kapoor, A., Zambon, J., Ciancio, S., Schneir, M. et al. (1984). Tetracyclines inhibit tissue collagenase activity. A new mechanism in the treatment of periodontal disease. J Periodontal Res 19, 651-5.   53  Golub, L. M., Siegel, K., Ramamurthy, N. S. and Mandel, I. D. (1976). Some characteristics of collagenase activity in gingival crevicular fluid and its relationship to gingival diseases in humans. J Dent Res 55, 1049-57.  Goodson, J. M. (2003). Gingival crevice fluid flow. Periodontol 2000 31, 43-54.  Goules, A., Tzioufas, A. G., Manousakis, M. N., Kirou, K. A., Crow, M. K. and Routsias, J. G. (2006). Elevated levels of soluble CD40 ligand (sCD40L) in serum of patients with systemic autoimmune diseases. Journal of autoimmunity 26, 165-71.  Graves, D. (2008). Cytokines that promote periodontal tissue destruction. J Periodontol 79, 1585-91.  Gremmel, T., Frelinger, A. L., 3rd and Michelson, A. D. (2016). Platelet Physiology. Semin Thromb Hemost 42, 191-204.  Griffiths, G. S. (2003). Formation, collection and significance of gingival crevice fluid. Periodontol 2000 31, 32-42.  Griffiths, G. S., Wilton, J. M. and Curtis, M. A. (1992). Contamination of human gingival crevicular fluid by plaque and saliva. Arch Oral Biol 37, 559-64.  Griffiths, G. S., Wilton, J. M. and Curtis, M. A. (1997). Permeability of the gingival tissues to IgM during an experimental gingivitis study in man. Arch Oral Biol 42, 129-36.  Hajishengallis, G. (2010). Complement and periodontitis. Biochem Pharmacol 80, 1992-2001.  Hajishengallis, G. (2014). Immunomicrobial pathogenesis of periodontitis: keystones, pathobionts, and host response. Trends Immunol 35, 3-11.  Hajishengallis, G., Chavakis, T., Hajishengallis, E. and Lambris, J. D. (2014). Neutrophil homeostasis and inflammation: novel paradigms from studying periodontitis. Journal of leukocyte biology.  Hajishengallis, G. and Sahingur, S. E. (2014). Novel inflammatory pathways in periodontitis. Adv Dent Res 26, 23-9.  Han, X. and Amar, S. (2003). Role of insulin-like growth factor-1 signaling in dental fibroblast apoptosis. J Periodontol 74, 1176-82.  Hasan, A. and Palmer, R. M. (2014). A clinical guide to periodontology: pathology of periodontal disease. Br Dent J 216, 457-61.  Havemose-Poulsen, A. and Holmstrup, P. (1997). Factors affecting IL-1-mediated collagen metabolism by fibroblasts and the pathogenesis of periodontal disease: a review of the literature. Crit Rev Oral Biol Med 8, 217-36.  Hienz, S. A., Paliwal, S. and Ivanovski, S. (2015). Mechanisms of Bone Resorption in Periodontitis. J Immunol Res 2015, 615486.  Holt, S. C. and Ebersole, J. L. (2005a). Porphyromonas gingivalis, Treponema denticola, and Tannerella forsythia: the "red complex", a prototype polybacterial pathogenic consortium in periodontitis. Periodontology 2000 38, 72-122.  How, K. Y., Song, K. P. and Chan, K. G. (2016). Porphyromonas gingivalis: An Overview of Periodontopathic Pathogen below the Gum Line. Front Microbiol 7, 53.  Huynh, A. H., Veith, P. D., McGregor, N. R., Adams, G. G., Chen, D., Reynolds, E. C., Ngo, L. H. and Darby, I. B. (2015). Gingival crevicular fluid proteomes in health, gingivitis and chronic periodontitis. J Periodontal Res 50, 637-49.   54  Ingman, T., Tervahartiala, T., Ding, Y., Tschesche, H., Haerian, A., Kinane, D. F., Konttinen, Y. T. and Sorsa, T. (1996). Matrix metalloproteinases and their inhibitors in gingival crevicular fluid and saliva of periodontitis patients. J Clin Periodontol 23, 1127-32.  Johnson, R. B., Streckfus, C. F., Dai, X. and Tucci, M. A. (1999). Protein recovery from several paper types used to collect gingival crevicular fluid. J Periodontal Res 34, 283-9.  Kaslick, R. S., Chasens, A. I., Weinstein, D. and Waldman, R. (1968). Ultramicromethod for the collection of gingival fluid and quantitative analysis of its sodium content. J Dent Res 47, 1192.  Kayal, R. A. (2013). The role of osteoimmunology in periodontal disease. Biomed Res Int 2013, 639368.  Kennett, C. N., Cox, S. W. and Eley, B. M. (1997). Investigations into the cellular contribution to host tissue proteases and inhibitors in gingival crevicular fluid. J Clin Periodontol 24, 424-31.  Kido, J., Bando, M., Hiroshima, Y., Iwasaka, H., Yamada, K., Ohgami, N., Nambu, T., Kataoka, M., Yamamoto, T., Shinohara, Y. et al. (2012). Analysis of proteins in human gingival crevicular fluid by mass spectrometry. J Periodontal Res 47, 488-99.  Kiili, M., Cox, S. W., Chen, H. Y., Wahlgren, J., Maisi, P., Eley, B. M., Salo, T. and Sorsa, T. (2002). Collagenase-2 (MMP-8) and collagenase-3 (MMP-13) in adult periodontitis: molecular forms and levels in gingival crevicular fluid and immunolocalisation in gingival tissue. J Clin Periodontol 29, 224-32.  Klebanoff, S. J. (2005). Myeloperoxidase: friend and foe. Journal of leukocyte biology 77, 598-625.  Kornman, K. S., Crane, A., Wang, H. Y., di Giovine, F. S., Newman, M. G., Pirk, F. W., Wilson, T. G., Jr., Higginbottom, F. L. and Duff, G. W. (1997). The interleukin-1 genotype as a severity factor in adult periodontal disease. J Clin Periodontol 24, 72-7.  Kowolik, M. J. and Raeburn, J. A. (1980). Functional integrity of gingival crevicular neutrophil polymorphonuclear leucocytes as demonstrated by nitroblue tetrazolium reduction. J Periodontal Res 15, 483-91.  Kumar, B. P., Khaitan, T., Ramaswamy, P., Sreenivasulu, P., Uday, G. and Velugubantla, R. G. (2014). Association of chronic periodontitis with white blood cell and platelet count - A Case Control Study. Journal of clinical and experimental dentistry 6, e214-7.  Lambert, M. P., Rauova, L., Bailey, M., Sola-Visner, M. C., Kowalska, M. A. and Poncz, M. (2007). Platelet factor 4 is a negative autocrine in vivo regulator of megakaryopoiesis: clinical and therapeutic implications. Blood 110, 1153-60.  Lee, H. J., Kang, I. K., Chung, C. P. and Choi, S. M. (1995). The subgingival microflora and gingival crevicular fluid cytokines in refractory periodontitis. J Clin Periodontol 22, 885-90.  Leppilahti, J. M., Hernandez-Rios, P. A., Gamonal, J. A., Tervahartiala, T., Brignardello-Petersen, R., Mantyla, P., Sorsa, T. and Hernandez, M. (2014). Matrix metalloproteinases and myeloperoxidase in gingival crevicular fluid provide site-specific diagnostic value for chronic periodontitis. J Clin Periodontol 41, 348-56.  Li, N., Hu, H., Lindqvist, M., Wikstrom-Jonsson, E., Goodall, A. H. and Hjemdahl, P. (2000). Platelet-leukocyte cross talk in whole blood. Arteriosclerosis, thrombosis, and vascular biology 20, 2702-8.   55  Li, X., Iwai, T., Nakamura, H., Inoue, Y., Chen, Y., Umeda, M. and Suzuki, H. (2008). An ultrastructural study of Porphyromonas gingivalis-induced platelet aggregation. Thrombosis research 122, 810-9.  Lindhe, J., Lang, N. P. and Karring, T. (2008). Clinical periodontology and implant dentistry. Oxford ; Ames, Iowa: Blackwell Munksgaard.  Lindhe, J. and Rylander, H. (1975). Experimental gingivitis in young dogs. Scand J Dent Res 83, 314-26.  Listgarten, M. A. and Ellegaard, B. (1973). Experimental gingivitis in the monkey. Relationship of leukocyte counts in junctional epithelium, sulcus depth, and connective tissue inflammation scores. J Periodontal Res 8, 199-214.  Liu, C. Y., Battaglia, M., Lee, S. H., Sun, Q. H., Aster, R. H. and Visentin, G. P. (2005). Platelet factor 4 differentially modulates CD4+CD25+ (regulatory) versus CD4+CD25- (nonregulatory) T cells. Journal of immunology 174, 2680-6.  Lobene, R. R., Mankodi, S. M., Ciancio, S. G., Lamm, R. A., Charles, C. H. and Ross, N. M. (1989). Correlations among gingival indices: a methodology study. J Periodontol 60, 159-62.  Lockhart, P. B., Bolger, A. F., Papapanou, P. N., Osinbowale, O., Trevisan, M., Levison, M. E., Taubert, K. A., Newburger, J. W., Gornik, H. L., Gewitz, M. H. et al. (2012). Periodontal disease and atherosclerotic vascular disease: does the evidence support an independent association?: a scientific statement from the American Heart Association. Circulation 125, 2520-44.  Lockhart, P. B., Brennan, M. T., Sasser, H. C., Fox, P. C., Paster, B. J. and Bahrani-Mougeot, F. K. (2008). Bacteremia associated with toothbrushing and dental extraction. Circulation 117, 3118-25.  Loe, H., Anerud, A., Boysen, H. and Morrison, E. (1986). Natural history of periodontal disease in man. Rapid, moderate and no loss of attachment in Sri Lankan laborers 14 to 46 years of age. J Clin Periodontol 13, 431-45.  Loe, H. and Holm-Pedersen, P. (1965). Absence and Presence of Fluid from Normal and Inflamed Gingivae. Periodontics 3, 171-7.  Loe, H., Theilade, E. and Jensen, S. B. (1965). Experimental Gingivitis in Man. J Periodontol 36, 177-87.  Lowenhaupt, R. W. (1978). Human platelet chemotaxis: requirement for plasma factor(s) and the role of collagen. The American journal of physiology 235, H23-8.  Lowenhaupt, R. W. (1982). Human platelet chemotaxis can be induced by low molecular substance(s) derived from the interaction of plasma and collagen. Progress in clinical and biological research 89, 269-80.  Lowenhaupt, R. W., Silberstein, E. B., Sperling, M. I. and Mayfield, G. (1982). A quantitative method to measure human platelet chemotaxis using indium-111-oxine-labeled gel-filtered platelets. Blood 60, 1345-52.  Lu, W., Xu, D., Tu, R. and Hu, Z. (2013). Morphology of platelet Golgi apparatus and their significance after acute cerebral infarction. Neural Regen Res 8, 2134-43.  Luo, L., Xie, P., Gong, P., Tang, X. H., Ding, Y. and Deng, L. X. (2011). Expression of HMGB1 and HMGN2 in gingival tissues, GCF and PICF of periodontitis patients and peri-implantitis. Arch Oral Biol 56, 1106-11.   56  Lynch, S. E., Williams, R. C., Polson, A. M., Howell, T. H., Reddy, M. S., Zappa, U. E. and Antoniades, H. N. (1989). A combination of platelet-derived and insulin-like growth factors enhances periodontal regeneration. J Clin Periodontol 16, 545-8.  Mac Mullan, P. A., Peace, A. J., Madigan, A. M., Tedesco, A. F., Kenny, D. and McCarthy, G. M. (2010). Platelet hyper-reactivity in active inflammatory arthritis is unique to the adenosine diphosphate pathway: a novel finding and potential therapeutic target. Rheumatology 49, 240-5.  Mahmood, T. and Yang, P. C. (2012). Western blot: technique, theory, and trouble shooting. N Am J Med Sci 4, 429-34.  Mancini, S., Romanelli, R., Laschinger, C. A., Overall, C. M., Sodek, J. and McCulloch, C. A. (1999). Assessment of a novel screening test for neutrophil collagenase activity in the diagnosis of periodontal diseases. J Periodontol 70, 1292-302.  Mann, W. V. (1963). Correlation of Gingivitis Pocket Depth and Exudate from Gingival Crevice. Journal of Periodontology 34, 379-&.  McCulloch, C. A. (1994). Host enzymes in gingival crevicular fluid as diagnostic indicators of periodontitis. J Clin Periodontol 21, 497-506.  McManus, L. M. and Pinckard, R. N. (2000). PAF, a putative mediator of oral inflammation. Critical reviews in oral biology and medicine : an official publication of the American Association of Oral Biologists 11, 240-58.  Michalowicz, B. S. (1994). Genetic and heritable risk factors in periodontal disease. J Periodontol 65, 479-88.  Mogi, M., Otogoto, J., Ota, N. and Togari, A. (2004). Differential expression of RANKL and osteoprotegerin in gingival crevicular fluid of patients with periodontitis. J Dent Res 83, 166-9.  Mokeem, S. A., Vellappally, S., Preethanath, R. S., Hashem, M. I., Al-Kheraif, A. A. and Anil, S. (2014). Influence of smoking on clinical parameters and gingival crevicular fluid volume in patients with chronic periodontitis. Oral Health Dent Manag 13, 469-73.  Moughal, N. A., Adonogianaki, E., Thornhill, M. H. and Kinane, D. F. (1992). Endothelial cell leukocyte adhesion molecule-1 (ELAM-1) and intercellular adhesion molecule-1 (ICAM-1) expression in gingival tissue during health and experimentally-induced gingivitis. J Periodontal Res 27, 623-30.  Nair, B. C., Mayberry, W. R., Dziak, R., Chen, P. B., Levine, M. J. and Hausmann, E. (1983). Biological effects of a purified lipopolysaccharide from Bacteroides gingivalis. J Periodontal Res 18, 40-9.  Nanci, A. and Bosshardt, D. D. (2006). Structure of periodontal tissues in health and disease. Periodontol 2000 40, 11-28.  Nicu, E. A., Van der Velden, U., Nieuwland, R., Everts, V. and Loos, B. G. (2009a). Elevated platelet and leukocyte response to oral bacteria in periodontitis. Journal of Thrombosis and Haemostasis 7, 162-70.  Noelle, R. J. (1996). CD40 and its ligand in host defense. Immunity 4, 415-9.  Nylander, M., Lindahl, T. L., Bengtsson, T. and Grenegard, M. (2008). The periodontal pathogen Porphyromonas gingivalis sensitises human blood platelets to epinephrine. Platelets 19, 352-8.   57  Ohlsson, K., Olsson, I. and Tynelius-Bratthall, G. (1974). Neutrophil leukocyte collagenase, elastase and serum protease inhibitors in human gingival crevicles. Acta Odontol Scand 32, 51-9.  Ong, V. H., Evans, L. A., Shiwen, X., Fisher, I. B., Rajkumar, V., Abraham, D. J., Black, C. M. and Denton, C. P. (2003). Monocyte chemoattractant protein 3 as a mediator of fibrosis: Overexpression in systemic sclerosis and the type 1 tight-skin mouse. Arthritis Rheum 48, 1979-91.  Oppenheim, F. G. (1970). Preliminary observations on the presence and origin of serum albumin in human saliva. Helv Odontol Acta 14, 10-7.  Overall, C. M., Sodek, J., McCulloch, C. A. and Birek, P. (1991). Evidence for polymorphonuclear leukocyte collagenase and 92-kilodalton gelatinase in gingival crevicular fluid. Infect Immun 59, 4687-92.  Page, C. and Pitchford, S. (2013). Neutrophil and platelet complexes and their relevance to neutrophil recruitment and activation. International immunopharmacology 17, 1176-84.  Page, R. C. and Schroeder, H. E. (1976). Pathogenesis of inflammatory periodontal disease. A summary of current work. Lab Invest 34, 235-49.  Papapanagiotou, D., Nicu, E. A., Bizzarro, S., Gerdes, V. E., Meijers, J. C., Nieuwland, R., van der Velden, U. and Loos, B. G. (2009). Periodontitis is associated with platelet activation. Atherosclerosis 202, 605-11.  Payne, W. A., Page, R. C., Ogilvie, A. L. and Hall, W. B. (1975). Histopathologic features of the initial and early stages of experimental gingivitis in man. J Periodontal Res 10, 51-64.  Perez-Chaparro, P. J., Goncalves, C., Figueiredo, L. C., Faveri, M., Lobao, E., Tamashiro, N., Duarte, P. and Feres, M. (2014). Newly identified pathogens associated with periodontitis: a systematic review. J Dent Res 93, 846-58.  Pervushina, O., Scheuerer, B., Reiling, N., Behnke, L., Schroder, J. M., Kasper, B., Brandt, E., Bulfone-Paus, S. and Petersen, F. (2004). Platelet factor 4/CXCL4 induces phagocytosis and the generation of reactive oxygen metabolites in mononuclear phagocytes independently of Gi protein activation or intracellular calcium transients. Journal of immunology 173, 2060-7.  Petersen, F., Ludwig, A., Flad, H. D. and Brandt, E. (1996). TNF-alpha renders human neutrophils responsive to platelet factor 4. Comparison of PF-4 and IL-8 reveals different activity profiles of the two chemokines. Journal of immunology 156, 1954-62.  Rudrakshi, C., Srinivas, N. and Mehta, D. S. (2011). A comparative evaluation of hepatocyte growth factor levels in gingival crevicular fluid and saliva and its correlation with clinical parameters in patients with and without chronic periodontitis: A clinico-biochemical study. J Indian Soc Periodontol 15, 147-51.  Saboor, M., Ayub, Q., Ilyas, S. and Moinuddin. (2013). Platelet receptors; an instrumental of platelet physiology. Pak J Med Sci 29, 891-6.  Saito, I., Komiyama, K., Moro, I., Akachi, K., Shiomi, N., Ito, K., Murai, S. and Umemura, S. (1987). Ultrastructural and immunocytochemical characterization of polymorphonuclear leukocytes from gingival crevice in man. J Periodontol 58, 493-7.   58  Sanara, P. P., Shereef, M., Hegde, S., Rajesh, K. S., Arun Kumar, M. S. and Mohamed, S. (2015). Comparative analysis of gingival crevicular fluid beta-glucuronidase levels in health, chronic gingivitis and chronic periodontitis. J Pharm Bioallied Sci 7, S660-5.  Sandholm, L. (1984). Cells and cellular interactions in gingival crevice washings from patients with juvenile periodontitis. Scand J Dent Res 92, 436-42.  Scaldaferri, F., Lancellotti, S., Pizzoferrato, M. and De Cristofaro, R. (2011). Haemostatic system in inflammatory bowel diseases: new players in gut inflammation. World journal of gastroenterology : WJG 17, 594-608.  Scheuerer, B., Ernst, M., Durrbaum-Landmann, I., Fleischer, J., Grage-Griebenow, E., Brandt, E., Flad, H. D. and Petersen, F. (2000). The CXC-chemokine platelet factor 4 promotes monocyte survival and induces monocyte differentiation into macrophages. Blood 95, 1158-66.  Schroeder, H. E. (1970). Quantitative parameters of early human gingival inflammation. Arch Oral Biol 15, 383-400.  Schroeder, H. E. and Munzel-Pedrazzoli, S. (1973). Correlated morphometric and biochemical analysis of gingival tissue. Morphometric model, tissue sampling and test of stereologic procedures. J Microsc 99, 301-29.  Scott, D. A. and Krauss, J. (2012). Neutrophils in periodontal inflammation. Front Oral Biol 15, 56-83.  Semple, J. W., Italiano, J. E., Jr. and Freedman, J. (2011). Platelets and the immune continuum. Nat Rev Immunol 11, 264-74.  Semple, J. W., Milev, Y., Cosgrave, D., Mody, M., Hornstein, A., Blanchette, V. and Freedman, J. (1996). Differences in serum cytokine levels in acute and chronic autoimmune thrombocytopenic purpura: relationship to platelet phenotype and antiplatelet T-cell reactivity. Blood 87, 4245-54.  Seymour, G. J., Powell, R. N., Cole, K. L., Aitken, J. F., Brooks, D., Beckman, I., Zola, H., Bradley, J. and Burns, G. F. (1983). Experimental gingivitis in humans. A histochemical and immunological characterization of the lymphoid cell subpopulations. J Periodontal Res 18, 375-85.  Sfikakis, P. P., Charalambopoulos, D., Vaiopoulos, G. and Mavrikakis, M. (1999). Circulating P- and L-selectin and T-lymphocyte activation and patients with autoimmune rheumatic diseases. Clinical rheumatology 18, 28-32.  Sheth, T. S. and Verma, S. J. (2011). Analysis of aspartate aminotransferase in gingival crevicular fluid: A study with initial therapy. J Indian Soc Periodontol 15, 235-9.  Shimada, Y., Tabeta, K., Sugita, N. and Yoshie, H. (2013). Profiling biomarkers in gingival crevicular fluid using multiplex bead immunoassay. Archives of oral biology 58, 724-30.  Silva, N., Abusleme, L., Bravo, D., Dutzan, N., Garcia-Sesnich, J., Vernal, R., Hernandez, M. and Gamonal, J. (2015). Host response mechanisms in periodontal diseases. J Appl Oral Sci 23, 329-55.  Skapski, H. and Lehner, T. (1976). A crevicular washing method for investigating immune components of crevicular fluid in man. J Periodontal Res 11, 19-24.  Sloan-Lancaster, J., Evavold, B. D. and Allen, P. M. (1993). Induction of T-cell anergy by altered T-cell-receptor ligand on live antigen-presenting cells. Nature 363, 156-9.   59  Socransky, S. S., Haffajee, A. D., Cugini, M. A., Smith, C. and Kent, R. L., Jr. (1998). Microbial complexes in subgingival plaque. J Clin Periodontol 25, 134-44.  Sodek, J. and Overall, C. M. (1992). Matrix metalloproteinases in periodontal tissue remodelling. Matrix Suppl 1, 352-62.  Soell, M., Elkaim, R. and Tenenbaum, H. (2002). Cathepsin C, matrix metalloproteinases, and their tissue inhibitors in gingiva and gingival crevicular fluid from periodontitis-affected patients. J Dent Res 81, 174-8.  Sosne, G., Qiu, P., Goldstein, A. L. and Wheater, M. (2010). Biological activities of thymosin beta4 defined by active sites in short peptide sequences. FASEB J 24, 2144-51.  Srivastava, K., Field, D. J., Aggrey, A., Yamakuchi, M. and Morrell, C. N. (2010). Platelet factor 4 regulation of monocyte KLF4 in experimental cerebral malaria. PLoS One 5, e10413.  Stadnicki, A. (2012). Involvement of coagulation and hemostasis in inflammatory bowel diseases. Current vascular pharmacology 10, 659-69.  Stoller, N. H., Karras, D. C. and Johnson, L. R. (1990). Reliability of crevicular fluid measurements taken in the presence of supragingival plaque. J Periodontol 61, 670-3.  Sueda, T., Bang, J. and Cimasoni, G. (1969). Collection of gingival fluid for quantitative analysis. J Dent Res 48, 159.  Taylor, J. J., Preshaw, P. M. and Lalla, E. (2013). A review of the evidence for pathogenic mechanisms that may link periodontitis and diabetes. J Periodontol 84, S113-34.  Teeuw, W. J., Slot, D. E., Susanto, H., Gerdes, V. E., Abbas, F., D'Aiuto, F., Kastelein, J. J. and Loos, B. G. (2014). Treatment of periodontitis improves the atherosclerotic profile: a systematic review and meta-analysis. Journal of clinical periodontology 41, 70-9.  Tonetti, M. S., Imboden, M. A. and Lang, N. P. (1998). Neutrophil migration into the gingival sulcus is associated with transepithelial gradients of interleukin-8 and ICAM-1. J Periodontol 69, 1139-47.  Ts'ao, C. H. (1971). Rough endoplasmic reticulum and ribosomes in blood platelets. Scand J Haematol 8, 134-40.  Ujiie, Y., Oida, S., Gomi, K., Arai, T. and Fukae, M. (2007). Neutrophil elastase is involved in the initial destruction of human periodontal ligament. J Periodontal Res 42, 325-30.  Ukai, T., Yumoto, H., Gibson, F. C., 3rd and Genco, C. A. (2008). Macrophage-elicited osteoclastogenesis in response to bacterial stimulation requires Toll-like receptor 2-dependent tumor necrosis factor-alpha production. Infect Immun 76, 812-9.  Van Dyke, T. E., Levine, M. J., Tabak, L. A. and Genco, R. J. (1983). Juvenile periodontitis as a model for neutrophil function: reduced binding of the complement chemotactic fragment, C5a. J Dent Res 62, 870-2.  Vandercappellen, J., Van Damme, J. and Struyf, S. (2011). The role of the CXC chemokines platelet factor-4 (CXCL4/PF-4) and its variant (CXCL4L1/PF-4var) in inflammation, angiogenesis and cancer. Cytokine & growth factor reviews 22, 1-18.  Waddington, R. J., Moseley, R. and Embery, G. (2000). Reactive oxygen species: a potential role in the pathogenesis of periodontal diseases. Oral diseases 6, 138-51.  Watanabe, T., Kukita, T., Kukita, A., Wada, N., Toh, K., Nagata, K., Nomiyama, H. and Iijima, T. (2004). Direct stimulation of osteoclastogenesis by MIP-1alpha: evidence obtained from studies using RAW264 cell clone highly responsive to RANKL. J Endocrinol 180, 193-201.   60  Watson, S. P., Auger, J. M., McCarty, O. J. and Pearce, A. C. (2005). GPVI and integrin alphaIIb beta3 signaling in platelets. Journal of thrombosis and haemostasis : JTH 3, 1752-62.  Wetzel, K., Struyf, S., Van Damme, J., Kayser, T., Vecchi, A., Sozzani, S., Rommelaere, J., Cornelis, J. J. and Dinsart, C. (2007). MCP-3 (CCL7) delivered by parvovirus MVMp reduces tumorigenicity of mouse melanoma cells through activation of T lymphocytes and NK cells. Int J Cancer 120, 1364-71.  White, J. G. and Krumwiede, M. (1987). Further studies of the secretory pathway in thrombin-stimulated human platelets. Blood 69, 1196-203.  Wilton, J. M., Renggli, H. H. and Lehner, T. (1976). The isolation and identification of mononuclear cells from the gingival crevice in man. J Periodontal Res 11, 262-8.  Yoshida, H. and Granger, D. N. (2009). Inflammatory bowel disease: a paradigm for the link between coagulation and inflammation. Inflammatory bowel diseases 15, 1245-55.  Yu, K. M., Inoue, Y., Umeda, M., Terasaki, H., Chen, Z. Y. and Iwai, T. (2011). The periodontal anaerobe Porphyromonas gingivalis induced platelet activation and increased aggregation in whole blood by rat model. Thrombosis research 127, 418-25.  Yucel-Lindberg, T. and Bage, T. (2013). Inflammatory mediators in the pathogenesis of periodontitis. Expert Rev Mol Med 15, e7.  Zhang, G., Han, J., Welch, E. J., Ye, R. D., Voyno-Yasenetskaya, T. A., Malik, A. B., Du, X. and Li, Z. (2009a). Lipopolysaccharide stimulates platelet secretion and potentiates platelet aggregation via TLR4/MyD88 and the cGMP-dependent protein kinase pathway. J Immunol 182, 7997-8004.  Zucker, M. B. and Katz, I. R. (1991). Platelet factor 4: production, structure, and physiologic and immunologic action. Proc Soc Exp Biol Med 198, 693-702.    

Cite

Citation Scheme:

        

Citations by CSL (citeproc-js)

Usage Statistics

Share

Embed

Customize your widget with the following options, then copy and paste the code below into the HTML of your page to embed this item in your website.
                        
                            <div id="ubcOpenCollectionsWidgetDisplay">
                            <script id="ubcOpenCollectionsWidget"
                            src="{[{embed.src}]}"
                            data-item="{[{embed.item}]}"
                            data-collection="{[{embed.collection}]}"
                            data-metadata="{[{embed.showMetadata}]}"
                            data-width="{[{embed.width}]}"
                            async >
                            </script>
                            </div>
                        
                    
IIIF logo Our image viewer uses the IIIF 2.0 standard. To load this item in other compatible viewers, use this url:
http://iiif.library.ubc.ca/presentation/dsp.24.1-0313403/manifest

Comment

Related Items